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Healthcare and energy systems provide critical service to our society. Recent advancement in 
information technology has enabled these systems to keep retrieving and storing data. In this 
dissertation, we used machine learning, optimization techniques, and data from healthcare and 
energy systems to build predictive models and discover new knowledge to guide decision-making 
and improve the efficiency and sustainability of these systems. We also used optimization 
techniques to improve the efficiency of hyperparameter tuning for machine learning algorithms. 
Specifically, we built a dynamic daily prediction model for predicting heart failure patients’ 30-
day readmission risk. We built a prediction model to predict xerostomia (dry mouth) for head and 
neck cancer patients treated with radiotherapy and identified the influence pattern of radiation dose 
across head and neck on xerostomia. Using an economic equilibrium model combined with 
optimization techniques for calibration, we built the first global trade model for wood chip and 
analyzed how local renewable energy policy in the United States could affect the global wood chip 
trade and lead to deforestation in other world regions. Finally, we created a new method for tuning 





problem using stochastic gradient descent combined with dual coordinate descent method. We 
showed that the new method is more efficient than ad hoc empirical approaches. In summary, we 
demonstrated how machine learning and optimization techniques can improve the efficiency of 
healthcare and energy systems, and how optimization techniques can advance machine learning 
algorithms. 
 
 Scott Levin, Reader 
 Todd McNutt, Reader 
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Healthcare and energy systems are critical components of our modern society. New challenges are 
constantly rising within these systems. For instance, based on the World Health Organization, the 
United States has the highest health care cost as a percentage of its GDP (17.1%) per capita, among 
all nations in 2014. The same year, it was ranked by Bloomberg among the ten countries with the 
least efficient healthcare out of 55 countries studied. Not only is high healthcare cost a challenge, 
most importantly, we also want to improve the treatment effectiveness and patients’ quality of life. 
On the other hand, for energy systems, ensuring effective renewable energy policies is crucial to 
mitigate climate change and reduce carbon emissions. However, reducing healthcare costs, 
improving patient treatment outcomes, and ensuring effective renewable energy policies are 
complex issues. In this dissertation, we attempted to provide our contribution to addressing a 
subset of these complex questions through an engineering approach, precisely, using machine 






Machine learning and artificial intelligence is becoming more and more powerful and 
changing the way we live. Meanwhile, patients’ data and renewable energy trade data have been 
accumulating with the advances in information technology. We believe using machine learning 
and optimization informed by these data will improve the efficiency and inform better decision 
making for healthcare and energy systems. Throughout the dissertation, we will demonstrate how 
we contributed to improving the healthcare and energy systems using machine learning and 
optimization techniques. We also show how we are advancing the machine learning algorithms 
through more efficient hyper-parameter optimization techniques. 
In the next two sections, we describe a selected subset of the specific machine learning and 
optimization methods we mainly studied and applied for our research problems in detail. The 
fourth section of this chapter explains the particular research applications and contribution we 
made. The final section outlines the overall structure of this dissertation. 
1.1 Machine Learning Methods 
1.1.1 Supervised Learning 
Supervised learning is a task of learning a function that maps inputs to the corresponding outputs 
from a given set of input-output examples [1]. Then we can use the learned function to predict the 
value of outputs given the inputs. The inputs and outputs are also called features and 






predictors/independent variables, and the outputs have been called responses/dependent variables 
[2]. The input-output pairs provided is the training data for the learning task. Depending on the 
variable type of the outputs, the supervised learning task is often categorized into two different 
types: classification and regression. If the outputs are categorical variables or qualitative variables 
such as color, of which the values don’t have an explicit ordering, the learning task is called 
classification. If the outputs are quantitative variables, such as housing price, of which the values 
have an explicit ordering, the learning task is called regression. Many different algorithms exist 
for the classification and regression tasks. In the dissertation, we mainly applied and studied 
classification algorithms, specifically, logistic regression models, with and without ridge and lasso 
regularization, 𝐾 -means clustering [2], stochastic gradient descent, and coordinate descent 
methods. Support vector machines [3] is described in detail in Chapter 5. 
Let’s define the input data as vectors 𝒙𝑖 from feature space 𝑋 ∈ 𝑅
𝑝, 𝑖 ∈ {1, … 𝑁}, where 𝑝 
is the dimension of the input vector and 𝑁 is the number of training examples. Define 𝑦𝑖 as output 
labels from output space 𝑌 ∈ ℝ (for regression), or 𝑌 ∈ 𝒴 (for classification) where 𝒴 is the set of 
values for all the labels. We aim to learn a function 𝑓(𝒙): 𝑋 → 𝑌 that can predict 𝑦. To learn the 
function, 𝑓(𝒙), many different learning algorithms have been developed. The learning task usually 
results in an optimization problem in which an empirical loss function, 𝐿(𝑓(𝒙), 𝑦), is used as the 
objective function. Various loss functions exist such as mean square error (often used for 






logistic regression). Given a specific learning algorithm and loss function, minimizing the loss on 
the training data using an optimization technique will yield the function 𝑓(𝒙).  
1.1.1.1 Logistic Regression 
The logistic regression model is a popular classifier that directly models the posterior probabilities 
of 𝐾 classes using a logistic function, also called the sigmoid function as follows: 
 
𝑃(𝑌 = 1|𝑋 = 𝒙) =
𝑒(𝜷𝟏
𝑇𝒙+𝛽10)






𝑃(𝑌 = 2|𝑋 = 𝒙) =
𝑒(𝜷𝟐
𝑇𝒙+𝛽20)




 ⋮  
 
𝑃(𝑌 = 𝐾|𝑋 = 𝒙) =
1






This logistic function formulation ensures that 𝑃(𝑌 = 𝑘|𝑋) ∈ (0,1), 𝑘 ∈ {1, … , 𝐾} and 
∑ 𝑃(𝑌 = 𝑘|𝑋) = 1𝑘 . 𝜷𝑖  and 𝛽𝑖0  are the model parameters to be learned, also called feature 
weights.  
Logistic regression is a linear classifier as the decision function defined by 𝜷𝒊
𝑇𝒙 + 𝛽𝑖0 is a 
linear function in the input data 𝒙. As a result, the decision boundary that separates the input feature 
space by logistic regression is also linear. We can ignore the bias term 𝛽𝑖0  to simplify the 








𝑇 , 1],     𝜷𝑇 ← [𝜷, 𝛽0] (1.2) 
For binary classification tasks, i.e., 𝑌 ∈ {0,1}, the above formulation simply reduces to 
 













A measure of interest is the odds ratio, often used as a more intuitive estimate of the effect 
size of certain input feature on the outcome probabilities. For instance, to estimate the effect size 
of input feature 𝑥1 on predicting 𝑃(𝑌 = 1|𝑥1, 𝑥2, … , 𝑥𝑝) over 𝑃(𝑌 = 0|𝑥1, 𝑥2, … , 𝑥𝑝) conditional 
on that the values of other features 𝑥2, 𝑥3, … , 𝑥𝑝 are fixed, the odds ratio is: 
 𝑃(𝑌 = 1|𝑥1 = 1, 𝑥2, … , 𝑥𝑝)
𝑃(𝑌 = 0|𝑥1 = 1, 𝑥2, … , 𝑥𝑝)
𝑃(𝑌 = 1|𝑥1 = 0, 𝑥2, … , 𝑥𝑝)








= 𝑒𝛽1 (1.4) 
Therefore, a positive weight 𝛽𝑖 indicates an odds ratio larger than one and feature 𝑥𝑖  is 
positively associated with predicting 𝑌 as one. A negative weight 𝛽𝑖 indicates an odds ratio smaller 
than one and feature 𝑥𝑖 is negatively associated with predicting 𝑌 as one. A zero weight 𝛽𝑖 means 






 The weights of the logistic regression model are typically estimated by fitting the training 
data by maximum likelihood estimation. The conditional likelihood of seeing 𝑦1, 𝑦2, … , 𝑦𝑛 given 
𝒙1, 𝒙2, … , 𝒙𝑛 is: 
 




Log-likelihood is usually maximized instead for mathematical convenience. 
 




Next, we show how the log-likelihood function can be maximized using the Newton-
Raphson algorithm with a binary classification example, which significantly simplifies the 
derivation.  
Inserting Eq. (1.3) into (1.6) and rewriting, we obtain: 






= ∑ 𝑙𝑜𝑔𝑃(𝑌 = 1|𝑋 = 𝒙𝑖)
























To maximize 𝑙(𝜷), we can set its first order condition to be 0. 
 𝜕𝑙(𝜷)
𝜷




This is a system of 𝑝 + 1 nonlinear equations and a Newton-Raphson algorithm is typically used 
to solve them [4].  
Logistic regression is widely used because it provides well-calibrated probability 
estimates, which are very important for certain applications, such as risk modeling in finance. 
Probability estimates also make it straightforward to compute certain complex performance 
metrics, such as area under the receiver operating characteristic curve (AUC) [5]. As for other 
supervised learning algorithms, such as support vector machines that don’t yield probability 
estimates, another algorithm needs to be used to obtain a probability measure for the outcome to 
compute the AUC score. As a simple linear classifier, the results of logistic regression are also 
easy to interpret. For instance, the p-values associated with the weights indicate whether certain 
features are statistically significantly different from zero. The sign of the weights indicates whether 
the outcome and the inputs are positive or negatively associated. In other words, the logistic 






However, as an example of generalized linear models, logistic regression won’t lead to 
valid statistical inference when the issue of multicollinearity is present, or the number of features 
is larger than the number of training examples. Specifically, when the number of features exceeds 
the number of training examples, the linear system of equations (1.8) has more variables than the 
number of equations. As a result, Eq. (1.8) doesn’t have unique solutions and the solutions for the 
weights have high variance (sensitive to slight changes in input data). The issue makes it unreliable 
for statistical inference. Besides, the high variance may lead to poor generalization performance 
on unseen test data [6]. Next, we introduce two regularization techniques that are often used to 
deal with this issue. 
1.1.1.2 Ridge and Lasso Regularization 
Ridge and lasso regularization are two general regularization techniques. They are often used to 
control model complexity and prevent overfitting for supervised learning models. They are widely 
used with many different supervised learning algorithms such as generalized linear models, 
support vector machines, and neural networks. Ridge regularization adds the 𝑙2 -norm of the 
weights as a penalty term to the original loss function, while lasso regularization adds the 𝑙1-norm 
of the weights as a penalty term [2][6]. Next, we use logistic regression as an example to describe 






 The loss function, negative log-likelihood of logistic regression is provided in Eq. (1.7). 
For ridge regularization, after adding the 𝑙2-norm of the weights to the loss function, we obtain the 
new loss function: 
 





For lasso regularization, we add the 𝑙1-norm of the weights to the loss function and obtain 
the new loss function: 
 




where λ is the regularization hyper-parameter that controls the extent of regularization. As a hyper-
parameter, it has to be exogenously set before we train the logistic regression model. In practice, 
the hyper-parameter is often tuned by cross-validation to prevent overfitting.  
 By adding a penalty term of the weights into the objective functions, ridge and lasso 
increase the bias of the estimation but reduce the variance of the estimation as the penalty term 
shrinks the value of the weights. How much variance ridge and lasso reduces is controlled by the 
value of the regularization hyper-parameter 𝜆. A large value of 𝜆 will lead to very small values of 
the weights 𝛽𝑖.  
 The advantage of ridge and lasso is that they both work well for high dimensional feature 






the variance of the estimation, they can prevent overfitting and improve the model’s 
generalizability on unseen test data. The difference between these two methods is that lasso 
induces sparsity into the solution due to 𝑙1-norm regularization but ridge doesn’t. As a result, the 
lasso is often used for feature selection, i.e., selecting a subset of predictive features from the 
original feature set. Ridge regularization uses a smooth 𝑙2-norm regularization. Thus, it doesn’t 
induce a sparse solution, rather shrinks the weights of nonimportant features close to zero and 
penalizes large weights. Another difference between ridge and lasso is their usage for statistical 
inference given correlated input features. According to Friedman et al. (2010)’s study [7], ridge 
regularization shrinks the weights of correlated features towards each other (it will assign equal 
weights to k identical input features). Ridge works well for the case when there are many input 
features and all of them have a non-zero effect on the output. On the other hand, lasso tends to 
select one of the correlated features and set the weights of the other correlated features as zero [7]. 
These characteristics are further explored in Chapter 3. A coordinate descent method has also been 
successfully applied to solve generalized linear models with ridge and lasso regularizations 
[2][6][7].  
1.1.2 Unsupervised Learning 
Unsupervised learning is a task in which an algorithm or agent learns the patterns in input data 
while no explicit output is provided [1]. As the most common unsupervised learning task, 






examples identified to be within the same cluster are close to each other given certain distance or 
dissimilarity measure. In this thesis, the 𝐾-means clustering method was used in Chapter 2 and we 
will describe it in detail here. 
 The 𝐾-means clustering algorithm is an iterative method that uses the squared Euclidean 
distance as its dissimilarity measure [2]. The squared Euclidean distance between input example 
𝑥𝑖 and 𝑥𝑗 is: 
 
𝐷(𝑥𝑖, 𝑥𝑗) = ‖𝑥𝑖 − 𝑥𝑗‖





The within-cluster sum of squares (WCSS) measure the total distance between all the input 
examples within a cluster and the center or mean vector of that cluster. Let’s define 𝜇𝑖 as the mean 
vector of the cluster 𝑆𝑖 and there are 𝑘 clusters. Then the total WCSS for the input data is: 
 

















1. Choose the number of clusters 𝑘. Initialize the algorithm by randomly assign a label 
from the 𝑘 cluster labels to each of the input examples.  





∑ 𝑥𝑖𝑥𝑖∈𝑆𝑖  
3. Assign each input example to the nearest cluster, i.e.,  
‖𝑥𝑖 − 𝜇𝑝
𝑡 ‖2 ≤  ‖𝑥𝑖 − 𝜇𝑗
𝑡‖2 ∀𝑗: 1 ≤ 𝑗 ≤ 𝑘.  
where 𝑝 is the new cluster label for input example 𝑥𝑖. 
4. Repeat step 2-3 until the cluster assignment doesn’t change. 
 
As this is a heuristic and the optimal solution is not guaranteed, often the algorithm is 
repeated multiple times with different random initializations in step 1. The results with the lowest 
WCSS is picked as the final cluster assignment result. In practice, the elbow method, or formally, 
gap statistic is typically used to estimate the optimal number of clusters [8]. 
In Chapter 2, we used this algorithm to perform clustering on the time series data of predicted 
daily readmission risk. As a result, we detected different dynamic risk readmission patterns from 






1.2 Optimization Methods 
1.2.1 Stochastic Gradient Descent 
In this big data era, the increase of data size often exceeds the increase of processor speed. Fast 
and simple optimization methods that work well for large-scale data problems have been a popular 
research topic for the last decade. First-order gradient methods have seen great success in solving 
large-scale problems. Among them, the stochastic gradient descent (SGD) is the most popular and 
an asymptotically efficient method, especially as the technique predominantly used for solving 
deep neural networks [9].  
Let’s denote the loss function for our machine learning task as 𝐿(𝑓(𝑥; 𝛽), 𝑦), where the 
function 𝑓(𝑥; 𝛽) is what we are learning to make predictions, 𝛽 is the model parameters, 𝑥 and 𝑦 
are the input and output of the data examples. Let’s denote the distribution of data examples as 
𝑃(𝑋) which is often unknown in practice. To learn function 𝑓(𝑥; 𝛽), we want to minimize the 
expected loss over the distribution 𝑃(𝑋) , i.e., 𝐸(𝑓) = ∫ 𝐿(𝑓(𝑥𝑖; 𝛽), 𝑦𝑖)𝑑𝑃(𝑋) . As 𝑃(𝑋 ) is 




∑ 𝐿(𝑓(𝑥𝑖; 𝛽), 𝑦𝑖)
𝑛
1 , where 𝑛 is the number of data examples. 
Gradient descent has been proposed to minimize the empirical risk [10]. The gradient of 
𝐸𝑛(𝑓) with respect to the weight parameter 𝛽  is ∇𝛽𝐸𝑛(𝑓) =
1
𝑛
∑  ∇𝛽𝐿(𝑓(𝑥𝑖; 𝛽), 𝑦𝑖)
𝑛






descent is an iterative numerical optimization algorithm which updates the weight parameter 𝛽 in 
each iteration using: 
 
𝛽𝑡+1 = 𝛽𝑡 − 𝛼
1
𝑛




where 𝛼 is the step size chosen to update the weight parameter.  
 As an even simpler method, instead of computing the full gradient of ∇𝛽𝐸𝑛(𝑓) using all 
the data examples, SGD estimates the gradient ∇𝛽𝐸𝑛(𝑓)  by randomly picking a single data 
example 𝑥𝑡. Then each iteration of updating the weight parameter becomes: 
 𝛽𝑡+1 = 𝛽𝑡 − 𝛼𝑡∇𝛽𝐿(𝑓(𝑥𝑡; 𝛽), 𝑦𝑡) (1.14) 
 It’s shown ∇𝛽𝐿(𝑓(𝑥𝑡; 𝛽), 𝑦𝑡) is an unbiased noisy gradient estimate of ∇𝛽𝐸𝑛(𝑓) and in 
expectation, parameter update Eq. (1.14) will be the same as Eq. (1.13). Under conditions: ∑ 𝛼𝑡
2
𝑡 <
∞ and ∑ 𝛼𝑡𝑡 = ∞, SGD will converge to the optimum solution [9].  
 For large datasets, estimating one full gradient is computationally expensive, while the 
gradient update in SGD is much cheaper. The advantage of SGD is that it’s simple and efficient. 
The disadvantages are that it requires tuning of some hyper-parameters, e.g., the step size/learning 
rate 𝛼𝑡, and it’s sensitive to input feature scales. We used SGD to optimize the hyper-parameter of 






1.2.2 Coordinate Descent 
Like gradient descent, coordinate descent (CD) [11] is also an iterative numerical optimization 
method. It has also gained recent popularity due to its successful application to solve machine 
learning problems, for instance, optimizing large-scale support vector machine problems [12]. 
Unlike gradient descent, in each iteration, CD chooses to optimize only one parameter variable 
while fixing the values of all the other parameter variables. Various mechanisms exist to cycle 
through all the parameter updates. During each iteration, CD is a solving a subproblem and often 
much easier than solving the full problem, for instance, when you can simply analytically derive 
the optimal solution for the subproblem but not for the full problem.  
 Using the previous empirical risk minimization problem as an example, the general steps 














Coordinate Descent Algorithm 
1. Initialize 𝑘 to be 0, and 𝛽0 ∈ ℝ𝑝 
2. Repeat: 
2 . 1  Choose an index 𝑖𝑘 ∈ {1,2, … , 𝑝}, which is the index for one parameter 
variable in the parameter vector 𝛽. 
2 . 2  𝛽𝑘+1 ← 𝛽𝑘 − 𝛼𝑘[∇𝛽𝐸𝑛(𝑓𝛽𝑘)]𝑖𝑘
𝑒𝑖𝑘  for some 𝛼𝑘 > 0 and 𝑒𝑖𝑘  is a vector 
whose 𝑖𝑘’s element is one and all other elements are zero. 
2 . 3  𝑘 ← 𝑘 + 1  
3. Until stopping criteria satisfied.  
 
The CD method was studied and successfully applied in Chapter 5. 
1.3 Applications and Contribution 
In this section, we describe our use of the above machine learning and optimization techniques. 
Also, we highlight the challenges and complexity of each project and explain how we applied the 






summarize the contribution and importance of our work in each project, as well as the overall 
contribution of the dissertation.  
1.3.1 Machine Learning in Healthcare 
Machine learning techniques have advanced rapidly and been successfully applied to solve 
problems in various fields such as natural language processing, computer vision, and robotics. 
Recently, with the increasingly available healthcare data, researchers have been actively applying 
machine learning techniques to solve problems in healthcare, such as disease diagnosis and 
treatment outcome risk prediction.  
Unlike the application of machine learning in other fields, machine learning application in 
healthcare faces several challenges and also opportunities. First, patients’ life and safety are so 
important that any prediction model built using machine learning techniques needs to be very 
accurate to be practically used in clinical settings. The users of the prediction model have to be 
able to control the false negative rate and false positive rate. For instance, for cancer diagnosis, if 
a cancer patient was falsely diagnosed as not having cancer by the prediction model, the patient 
could die or miss the early treatment. On the other hand, if a non-cancer patient was falsely 
diagnosed as having cancer by the prediction model, the patient could receive unnecessary 
treatment that could cause side effects and higher healthcare costs. In healthcare settings, a false 






Therefore, it’s extremely important for the physicians to be able to control for the false negative 
rate.  
Second, the high complexity of human disease and biological mechanism make applying 
machine learning models very challenging. Machine learning may be able to provide accurate 
predictions or discover new knowledge in healthcare, but physicians’ expertise will always be 
required to make actual decisions to treat the patients. Therefore, how to bridge the gap between 
machine learning models physicians’ decision making is a key step to successfully leveraging 
machine learning techniques in healthcare. For instance, assume we have obtained an accurate 
readmission risk prediction for a patient, the physicians still need to decide what interventions to 
provide to effectively reduce the readmission risk for that patient. A prediction model that also 
provides important potential driving factors that affect the readmission risk will be informative for 
physicians’ decision-making, while a prediction model itself is informative enough in this case. 
Third, each patient is unique and has different characteristics from other patients. The same 
drug may be effective for one patient but not for another patient. Therefore, precision medicine 
was proposed to provide customized medical treatment for each patient. To achieve the goal of 
precision medicine, machine learning techniques are promising as they can take each patient’s 
characteristics; such as genomic data, clinical history, and diagnosis information; into account and 






learning models over traditional statistical analysis, which typically draws conclusions on the 
population level.  
In conclusion, machine learning techniques are promising and have great potential to 
advance the field of healthcare but face critical challenges that need to be overcome to prove its 
practical value. 
1.3.2 Knowledge Discovery and Prediction 
Machine learning and optimization methods can be used both for knowledge discovery and 
prediction. In many applications in industry, such as demand forecasting, loan default prediction, 
and advertisement click-through rate prediction, an accurate prediction is most important. The user 
may care less about discovering new knowledge from the database. However, that’s often not the 
case in the context of medicine.  
In medicine, the physicians not only need an accurate prediction model for tasks such as 
toxicity prediction or disease diagnosis but are also interested in discovering new knowledge about 
the toxicity or disease. The physicians want to investigate the clinical and administrative factors 
that are causing toxicity and diseases. Often knowledge discovery is more important than obtaining 
an accurate prediction model. If we know the important factors which are causing certain 
outcomes, the physicians can then provide effective targeted interventions to improve patients’ 
treatment outcome. Merely knowing an accurate prediction for a patient is not good enough since 






words, knowledge discovery may be more valuable than prediction regarding helping physicians 
with their decision making. 
Knowledge discovery is a task where the users want to discover new knowledge or pattern 
from the database. Various machine learning models have been used for knowledge discovery. For 
instance, using logistic regression, lasso regularization, or random forest models to find the most 
critical features and perform feature selection; or using clustering algorithms to find potential 
patterns and clusters in the dataset.  
Unlike knowledge discovery, the goal of prediction is to predict an outcome 𝑌 given input 
data 𝑋 using a function 𝑓(𝑋). To achieve good prediction performance, often complex black-box 
models such as deep neural networks are used, which are difficult to interpret. On the other hand, 
knowledge discovery often utilizes more interpretable models rather than black-box machine 
learning models, as an accurate prediction is not the primary goal.  
For our heart failure readmission risk prediction model, we focus both on accurate 
prediction and knowledge discovery regarding the driving factors for readmission. For the 
radiation oncology project, we mainly focus on knowledge discovery regarding the investigating 
the influence of spatial radiation dose pattern on patients’ xerostomia outcome. 
1.3.2.1 Readmission Risk Prediction 
Heart failure is a leading cause of hospitalization with a high 30-day readmission rate of about 






healthcare cost. The goal of this project is to build a dynamic daily prediction model for 30-day 
readmission risk for heart failure patients. The prediction model can help hospitals target patients 
that have high readmission risks with interventions to reduce readmission rate. The challenge is 
that the readmission risk (i.e., the outcome label), if the patients were discharged earlier, is 
unknown. Another challenge is that predicting readmission risk itself is a hard problem and 
existing models usually have poor prediction performance. To deal with these challenges, we came 
up with a two-stage modeling approach in which we combined classification and regression 
techniques. More specifically, at the first stage, we trained a classification model to estimate the 
counterfactual daily readmission risk; at the second stage, we fitted a beta regression model using 
patient-day data and the estimated readmission risk outcome from the first stage. Finally, we 
obtained a dynamic daily readmission risk prediction model that can be used in practice, which is 
the trained beta regression model at the second stage. Further, we found four different risk 
readmission groups with different dynamic risk trajectories using clustering techniques. We also 
identified predictors that are most associated with the changing readmission risk. Our contribution 
is that due to unavailable true daily readmission risk data, we combined a classification model with 
a regression model to dynamically predict readmission risk and clustered different readmission 






1.3.2.2 Knowledge Discovery in Radiation Oncology 
Head and neck cancer patients often receive radiation therapy to kill cancer cells. However, the 
head and neck contain several organs and tissues that should not be overexposed to this radiation. 
Radiation induces side effects such as xerostomia, which is also called dry mouth. The goal of this 
work is to understand how radiation dose affects xerostomia for head and neck cancer patients. 
There are several main challenges for this work. First, there is not enough variation of radiation 
dose treatment in different subvolumes of organs across the patients, which makes it hard for the 
machine learning algorithms to detect the most sensitive regions. Second, the dose effect on 
xerostomia in different regions may have spatial dependency and radiation dose data alone is 
unable to identify the sensitivity of dose effect. To deal with those challenges, we performed a 
voxel-based radiation dose analysis by combining a radio-morphology model and machine 
learning algorithms. Specifically, we tried various machine learning algorithms (logistic regression 
with ridge, lasso regularization, random forest) and found out that ridge logistic regression is well 
suited to identify the influential subvolume regions given the high dimensional and spatially highly 
correlated radiation dose data. However, to further establish causal effect between dose and 
xerostomia, causal inference and clinical trials need to be conducted. For this work, our 
contribution is that, given limited patients’ radiation treatment data, we combined a radio-
morphology model with regularized supervised learning algorithms to learn dose effect on 






dose bath region, i.e., the superior portion of ipsilateral and contralateral parotid glands, to be most 
influential on acute xerostomia and xerostomia recovery.  
1.3.3 Renewable Energy Policy Analysis 
Traditionally, wood chip was used to produce paper, but it has also been used as biofuel. The US 
is considering including wood chip in its renewable fuel standard, which is a policy to reduce 
overall carbon emissions. But the US has been a major exporter of wood chip worldwide, and its 
exports of wood chip could decline if this resource is increasingly used for domestic electricity 
generation and biofuel production due to this policy. The research question we are investigating 
here is how local renewable energy policies in the US can affect global wood chip trade and carbon 
emissions. Through global trade of renewable bioenergy products, local renewable energy policies 
can impact the bioenergy production in other world regions. We need to estimate the global 
impacts of the local energy policies before we implement them. The challenge of this work is that 
the wood chip trade data is very limited. We were able to automatically calibrate our wood chip 
trade model under this data-limited setting using a primal-dual optimization technique. For this 
project, our contribution is that we build the first global wood chip trade model in the literature by 
combining a fundamental economic equilibrium model with top-down optimization methods to 






1.3.4 Hyper-parameter Optimization  
Hyper-parameter optimization is crucial to obtain a trained machine learning model that has good 
prediction performance. However, in practice, the methods used for hyper-parameter optimization 
are often empirical or ad hoc search methods such as grid search and random search. The challenge 
is that it’s computationally expensive to search the hyper-parameter space and more efficient 
methods are needed. We adopted a gradient-based approach and combined stochastic gradient 
descent and dual coordinate descent to optimize the hyper-parameter for Support vector machines. 
The contribution of this work is that we used fundamental gradient-based optimization methods 
for hyper-parameter optimization for a machine learning algorithm that enabled hyper-parameter 
tuning to evolve away from empirical ad hoc approaches.  
In summary, the overall contribution of this dissertation is that we integrated bottom-up, 
fundamentals-based models with top-down machine learning and optimization models in data-
limited settings with applications in healthcare and energy systems. We also advanced the method 
for hyper-parameter tuning for machine learning algorithms using optimization techniques. 
1.4 Outline 
Chapter 2 describes our work in building dynamic 30-day readmission risk prediction model for 
heart failure patients. It applies both supervised and unsupervised machine learning methods as 






Barnes, and Dr. Sauleh Siddiqui. This chapter was written for an academic journal and is planned 
to be submitted this year. Chapter 3 describes our work in the radiation oncology department. We 
demonstrated how to use machine learning methods to perform knowledge discovery on the 
relationship between radiation dose on radiotherapy side effects, particularly xerostomia, for head 
and neck cancer patients. The first half of the results of this chapter have been submitted for journal 
publication and are under review. This work was advised by Dr. Todd McNutt, Dr. Harry Quon, 
Dr. Sauleh Siddiqui, Dr. Ilya Shpitser, Dr. Russell Taylor, and completed together with Pranav 
Lakshminarayanan, Xuan Hui, Peijin Han, Sierra Cheng, who are our colleagues at the radiation 
oncology department at Johns Hopkins University. Chapter 4 describes our work on applying 
equilibrium modeling and optimization techniques for analysis on renewable policies of wood 
chip. This work was advised by Dr. Stephanie Searle and Dr. Sauleh Siddiqui and has been 
published as an academic journal article. Chapter 5 shows how we applied optimization techniques 
to improve the efficiency of building a support vector machine classifier, which is a popular 
supervised machine learning algorithm. The research was mainly advised by Dr. Sauleh Siddiqui. 
We plan to submit this work to a journal in the field of operations research.  
 Finally, we summarize the overall findings and conclusions of this dissertation, and also 









2 Heart Failure Patient Readmission Prediction 
2.1 Introduction  
Patients hospitalized with heart failure suffer the highest rates of 30-day readmission among any 
clinically-defined patient populations in the United States (US) [13]. National efforts to prevent 
avoidable hospitalizations have led to the adoption of 30-day readmission as a publicly reported 
performance measure linked to Medicare patient reimbursement [14]. This has motivated much 
investigation into the predictability of 30-day readmissions in-hospital to guide targeted 
interventions that could reduce risk. Clinical and administrative data available in hospital 
electronic health records (EHR) and clinical registries have been the primary data sources for these 
evaluations. Prior studies have applied traditional statistical- and machine-learning-based methods 






performance measured as the area under the receiver operating characteristic curve (AUC) has 
ranged from 0.55 to 0.76 [15][16][17][18][19][20]. 
In this study, a novel two-stage modeling approach to estimating patients’ readmission risk 
dynamically was created for a cohort of heart failure patients presenting to a community hospital. 
The study objective was to develop a predictive model of 30-day readmission that functions in 
real-time over the course of a patient’s hospitalization. We hypothesize that quantifying 
readmission risk trends has potential to illuminate the effects of clinical measures and interventions 
on readmission likelihood at discharge. This analysis further enabled the identification of heart 
failure patient groups with fundamental trajectories in readmission risk over their hospital 
encounter. 
2.2 Methods 
2.2.1 Setting and Data Source 
We conducted a retrospective cohort study of patient encounters with a primary diagnosis of heart 
failure between September 1, 2013, and August 31, 2015, from a community hospital in Columbia, 
Maryland. We identified heart failure patients using ICD9 codes: 428.x, 402.01, 402.11, 402.91, 
404.01, 404.03, 404.11, 404.13, 404.91, and 404.93 [21]. Encounters that resulted in mortality, 






534 unique encounters for 478 patients totaling 2750 patient-days. Data from the hospital EHR 
available as part of routine patient care was mined to establish our outcome and predictor variables. 
We employed a Centers for Medicare and Medicaid Services (CMS) [14] definition for 30-
day readmission as our primary outcome measure. This was defined as readmission to the same 
hospital within 30 days of discharge of the index hospitalization for all causes (i.e., not necessarily 
related to heart failure) [14].  
Hypothesized predictors were derived from heart failure and readmission risk factors used 
in previous studies as summarized in Table 2.1 [17][22][23][24][25][26][27]. Predictor data may 
be conceptually grouped into static (unchanged over the hospital encounter) or dynamic 
(fluctuating over the hospital encounter). Static predictors comprised demographics (age, gender, 
race), socio-economic status (insurance, marital status, zip code), healthcare utilization (discharge 
disposition, number of visits in the last six months), emergency department (ED) chief complaint 
clinically categorized [28][29], Charlson co-morbidity index at admission computed using active 
problems on patients’ problem list (medical history) [23][24], and admission diagnoses. 
Dynamic predictors comprised the elapsed length-of-stay at prediction time, vital signs 
(systolic blood pressure, diastolic blood pressure, temperature, respiratory rate, pulse, peripheral 
capillary oxygen) and lab results (Alanine Transaminase (ALT), Aspartate Transaminase (AST), 
Blood Urea Nitrogen (BUN), Creatinine, Hemoglobin, Potassium, Sodium, proBNP, Troponin T). 






series characteristics of these data were engineered as predictors. Each vital sign and laboratory 
measure (𝑥1, 𝑥2, … 𝑥𝑡) was transformed into the following predictors:  
1. Number of measurements: t 












4. Minimum: min (𝑥1, 𝑥2, … , 𝑥𝑡) 
5. Maximum: max (𝑥1, 𝑥2, … , 𝑥𝑡) 
6. Normalized index of the minimum: 
𝑖𝑛𝑑𝑒𝑥 𝑜𝑓 min (𝑥1,𝑥2,…,𝑥𝑡)
𝑡
 
7. Normalized index of the maximum: 
𝑖𝑛𝑑𝑒𝑥 𝑜𝑓 max (𝑥1,𝑥2,…,𝑥𝑡)
𝑡
 











𝑖=2 − 𝑥𝑖−1|  
Normalized index predictors were designed to capture the relative point during 






measurements have been taken over a patients’ stay at prediction time t and the 6th measurement 
is where the minimum occurred - the value of the normalized index of minimal temperature is 0.6.  
Missing values were observed for laboratory result data. For these cases, the patient may 
not have had certain tests conducted, or the test was conducted, but the results were not recorded 
into the EHR system. For the first case, we have, for instance, 70 out of 534 encounters did not 
have pro-B-type Natriuretic peptide test data, 55 encounters did not have Aspartate Transaminase 
test data, and 37 encounters did not have Troponin-T test data. Features with more than 30% data 
missing were excluded. For features with less than 30% missing data, we imputed the missing 
values using the mean value for the predictors across all the 534 encounters. For the second case, 
we hypothesized that the number of tests conducted might reflect the severity of a patient’s 
condition. Fewer tests may indicate a better patient condition. Therefore, we created predictors for 
the number of laboratory tests conducted. 
2.2.2 Daily Prediction Model 
The model was structured to yield a prediction of 30-day readmission risk each day (6 a.m.) in the 
patients’ encounter based on data available at that time-point in the EHR. Predictions were 
chronologically made at the time of hospital admission (first prediction), then 6 a.m. each 
subsequent day, and last at hospital discharge (last prediction). Thus, predictions made on day 1 
(6 a.m. day after admission) would have access to less predictor information than predictions made 






To obtain a daily prediction model, we used a two-stage modeling approach. In the first 
stage, we trained a classification model on the 534 encounter samples with their 30-day 
readmission labels as prediction target. Then, we used the trained classifier to estimate the daily 
readmission probability using patients-day data. Patients-day data consists of patients’ information 
accumulating until a certain day. In the second stage, we fit a beta regression model using patients-
day data as predictors and the estimated daily readmission probability as prediction target. There 
are two main reasons for using this two-stage approach. First, to ensure that training data and future 
daily prediction data are from the same distribution. Second, the counterfactual 30-day 
readmission risk if the patients were discharged earlier is unknown, and we used the first stage 
model to estimate it. 
Multiple classification algorithms (e.g., logistic regression, random forest, AdaBoost) were 
used to train the first stage model with logistic regression with backward stepwise selection 
yielding the best performance. The performance was evaluated out-of-sample through 5-fold 
cross-validation (80% training and 20% test).  
2.2.3 Patient Trajectory Cluster Analysis 
A patient’s daily 30-day readmission risk may change over the course of their hospitalization due 
to increased collection of information (i.e., more data available) and the evolution of their 
condition as therapies are administered. We applied 𝐾 -means clustering (unsupervised) to 






total of 75.0% of all laboratory tests, 60.5% of all procedures, and 85.9% of all medication orders 
occurred before the end of day 5 for our study cohort. Thus, the majority of variation in 
readmission probability occurred before this time. The unsupervised clustering approach was 
designed to learn potential trajectories (i.e., trends) in readmission risk that may naturally 
distinguish patient groups. Predictors that discern these different trajectories were then detected 
using Kruskal Wallis hypothesis testing.  
The specific steps used to train the predictive models, learn patient groups by trajectory, 
and identify predictors that discern these patient groups are summarized as follows: 
1. Train logistic regression model on the full data set using the selected set of predictors 
2. Estimate the probability of 30-day readmission for each patient-day using the trained 
classification model 
3. Fit a beta regression model using the patients-day data with same selected set predictors 
in step 1 as predictors and estimated readmission probability from step 2 as prediction 
target  
4. Assemble the time series of daily readmission probabilities predicted by the beta 
regression model for each patient encounter  
5. Apply the 𝐾 -means algorithm to cluster encounters into groups based on their 






6. Apply Kruskal-Wallis test to identify discriminative predictors associated with the 
different clusters 
Analyses were conducted using Python (version 2.7), the scikit-learn (version 0.18.1) and R 
(version 3.4.1), betareg (version 3.1-0). 
2.2.4 Partial Dependence of Predictors 
To investigate how individual predictors affect the predicted readmission risk in the fitted beta 
regression model, we created partial dependence plots. Partial dependence plots were proposed by 
Friedman (2001) to visualize the dependence of the prediction target 𝐹(𝒙) ̂ on the predictors 𝒙, i.e., 
how 𝐹(𝒙)̂ changes as a function of 𝒙 [32]. 𝐹(𝒙)̂ is the prediction model, in our case, the fitted beta 
regression model, and 𝒙 is the set of predictors.  
Assume we want to investigate the dependence of 𝐹(𝒙𝑠)̂ on a subset of predictors 𝒙𝑠 , 
which we call partial dependence. Denote the complement set of predictors as 𝒙𝑐. We have 𝒙𝑐 ∪
𝒙𝑠 = 𝒙 and 𝒙𝑐 ∩ 𝒙𝑠 = ∅. To compute 𝐹(𝒙𝑠)̂, we marginalize out the effect of 𝒙𝑐 on 𝐹(𝒙)̂. We 
have: 












where 𝑁 is the sample size of training data. In other words, 𝐹(𝒙𝑠)̂ is the averaged predicted 
value across all the training data while substituting predictor of interest 𝒙𝑠 with a certain value for 
all the training samples.  
2.3 Results 
2.3.1 Setting and Data Source 
Characteristics of the patient cohort stratified by the 30-day readmission outcome may be seen in 
Table 2.1. The logistic regression prediction model yielded an out-of-sample AUC of 0.73 (±0.08). 
Backward stepwise selection identified an optimal subset of 20 predictors (57 total). The pseudo-
R-squared value (squared correlation coefficient between outcomes and predicted values) for the 
beta regression is 0.88.  
 
Table 2.1 Descriptive summary of encounter data, stratified by 30-day readmission outcomes. 
Summary statistics for continuous variables (indicated by ‘*’) include the mean, median, and 
interquartile range. Some entries were left blank (marked as ‘/’) for the following predictors: 
predictors containing patient private information, complex predictors that are not straightforward 
to summarize in a single table such as time series predictors and the categorical features of which 
each patient has multiple values. 
Predictor Descriptive statistics 






(n = 427) (n = 107) 
Static predictors    





    Gender: Female 52.2% 59.8% 0.19 
    Marital status 
  
0.81 
        Married 39.3% 41.1%  
        Single 15.9% 17.8%  
        Widowed 34.4% 33.6%  
    Race 
  
0.96 
        White or Caucasian 60.4% 60.7%  
        Black or African American 28.3% 29.0%  
        Asian 8.4% 8.4%  
    Insurance 
  
0.46 
        Medicare 70.2% 74.8%  
        Commercial 21.5% 19.6%  
        Medicaid 3.0% 3.7%  
        Other 5.2% 1.9%  
    Discharge disposition 
  
0.35 
        Home or Self Care 64.6% 60.7%  
        Skilled Nursing Facility 14.5% 12.1%  






        Rehabilitation Facility 4.0% 5.6%  
        Short Term Hospital 1.9% 1.9%  
        Nursing Facility 1.2% 4.7%  
    Number of prior visits to hospital* 1.4, 1 (0-2) 2.2, 1 (0-3) 0.002 
    Chief complaints 
  
0.91 
        Shortness of breath 66% 59.8%  
        Chest pain 6.1% 6.5%  
        Edema 4% 5.6%  
        Weakness 3.5% 2.8%  
        Lower respiratory tract infection 2.8% 1.9%  
        Abdominal pain 2.1% 2.8%  
        General 1.6% 0.9%  
        Altered mental status 1.4% 0.9%  
        Genitourinary 1.2% 1.9%  
        Blunt trauma 1.2% 2.8%  
    ZIP code / /  
    Diagnoses / /  
    Diagnoses history / /  
Dynamic predictors    
    Elapsed length of stay* 4.8, 3.7  
(2.2-5.8) 
6.4, 4.2  
(2.6-7.3) 
0.02 








        Average ALT (Units/L) per         
patient* 
32.0, 20.0  
(13.3-30.0) 
28.0, 18.0  
(12.0-28.6) 
0.24 
        Average AST (Units/L) per patient*:  32.7, 24.0  
(18.0-35.0) 
32.3, 21.8  
(16.9-30.0) 
0.19 
        Average BUN (mg/dL) per patient* 28.5, 25.0  
(18.3-35.3) 
34.2, 30.8  
(20.0-44.7) 
6.05e-3 
        Average Creatinine (mg/dL) per 
patient* 
1.6, 1.2  
(1.0-1.6) 
1.9, 1.4  
(1.0-2.0) 
3.79e-3 
        Average Hemoglobin (mg/dL) per 
patient* 
11.4, 11.2  
(9.9-12.7) 
10.8, 10.4  
(9.1-12.3) 
2.55e-3 
        Average Potassium (mmol/L) per 
patient* 
4.2, 4.1  
(3.9-4.4) 
4.2, 4.1  
(3.9-4.4) 
0.83 










        Average Troponin T (pg/mL) per 
patient* 
37.1, 10.0  
(10.0-30.0) 
56.1, 14.2  
(10.0-52.7) 
0.14 
    Vital signs    
        Systolic blood pressure / /  
        Diastolic blood pressure / /  
        Temperature / /  
        Respiratory rate / /  
        Pulse / /  






    Weight / /  
    Past medical history / /  
    Medication order / /  
    Procedure / /  
 
2.3.2 Prediction Model 
2.3.2.1 First Stage Model 
As we mentioned in the previous methods section, we used a logistic regression model at the first 
stage. Table 2.2 summarizes the significant variables from the logistic regression prediction model 
at the first stage. Most of the significant predictors in Table 2.2 are clinical predictors such as 
laboratory test results and vital signs, specifically related to potassium, sodium, hemoglobin and 
diastolic blood pressure measurements. The number of medication orders for the digitalis 
glycosides pharmacy class, number of measurements of peripheral capillary oxygen saturation 
(SPO2), and number of hemodialyses performed are negatively associated with readmission 
likelihood. The number of measurements of sodium and number of mechanical ventilation 
procedures are both positively associated with readmission likelihood. Discharge disposition is a 
significant administrative predictor. The patients who were discharged to nursing facility 






because patients who were sicker are more likely to be sent to the nursing facilities. Another reason 
maybe patients cared by nurses were readmitted to hospitals more promptly. 
Table 2.2 Summary of significant predictors (p-values less than 0.05) for the logistic regression 
model with backward stepwise feature selection at discharge. The results are from the logistic 
regression model fitted on the entire dataset (534 encounters). 
Predictor Coefficient Odds ratio 95% CI p-values 
Normalized index of minimal 
Potassium 
-2.15 0.12 -3.27, -1.03 <0.001 
Number of measurements of SPO2 -0.07 0.93 -0.11, -0.03 0.001 
First minus last value of 
Hemoglobin 
0.56 1.75 0.20, 0.92 0.002 
Average Sodium -0.47 0.62 -0.78, -0.16 0.003 
Number of medication order: 
Digitalis Glycosides 
-0.67 0.51 -1.11, -0.23 0.003 
First minus last value of BUN -0.04 0.96 -0.07, -0.01 0.004 
Discharge Disposition: Nursing 
Facility 
2.36 10.59 0.62, 4.10 0.008 
Number of procedures: Mechanical 
Ventilation 
0.08 1.08 0.02, 0.14 0.008 
First minus last value of Diastolic 
Blood Pressure 
-0.02 0.98 -0.04, -0.01 0.008 
Minimal Sodium 0.35 1.60 0.07, 0.64 0.01 
Number of measurements of 
Sodium 






Normalized index of maximal 
Hemoglobin 
1.63 5.14 0.30, 2.98 0.02 
Number of measurements of 
Diastolic Blood Pressure 
0.05 1.05 0.01, 0.09 0.02 
Normalized index of minimal 
Sodium 
-1.21 0.30 -2.25, -0.18 0.02 
Average value of last 3 Diastolic 
Blood Pressure 
-0.05 0.96 -0.09, -0.004 0.03 
Normalized index of minimal 
Respiratory Rate 
1.12 3.07 0.10, 2.15 0.03 
ZIP code: 210XX 0.77 2.17 0.05, 1.50 0.04 
Number of procedure: 
Hemodialysis 
-0.41 0.67 -0.80, -0.01 0.04 
 
2.3.2.2 Second Stage Model 
After estimating the counterfactual daily readmission risk, we used beta regression as the second 
stage model. Beta regression models are often used to model variables that the values are in the 
range of (0,1) in practice [33]. There are two main assumptions behind beta regression. First, the 
dependent variable follows a beta distribution. Second, its mean value can be fitted using a linear 
predictor consists of the dependent variables/predictors.  
 We used beta regression for the following two reasons. First, the values of the predicted 
daily readmission risk from the first stage model are in the interval of (0,1). Second, we found the 






2.1 shows that the predicted readmission risk can be approximately represented using a beta 
distribution. Q-Q plot is the quantile-quantile plot [34]. It helps diagnose whether two datasets 
follow the same distribution. In our case, its y-axis represents the values of different quantiles in 
the empirical data (estimated readmission risk), and its x-axis is the value of the corresponding 
quantile in the fitted theoretical beta distribution. P-P plot is the probability-probability plot [35]. 
It helps diagnose if an empirical distribution follows a certain theoretical distribution. The 
difference between P-P plot and Q-Q plot is that, instead of using quantiles, P-P plot plots the 
values of the cumulative distribution functions of the empirical and theoretical distributions. The 
y-axis and x-axis of a P-P plot represent the values corresponds to different cumulative 
probabilities in the empirical distribution and theoretical distribution respectively. For both Q-Q 
plot and P-P plot, a straight line with a slope of one indicates the two datasets exactly follow the 
same distribution. CDF represents the cumulative distribution function. Similarly, a straight line 
with slope one in the third subplot ‘Empirical and theoretical CDF’ indicates that the empirical 
cumulative distribution is the same as the theoretical one (beta distribution here). The 
Kolmogorov-Smirnov goodness-of-fit test shows we can’t reject the null hypothesis that the 
predicted readmission risk follows a beta distribution [33].  
We fitted beta regression to the predicted readmission risk using the same set of predictors 
used by the first stage model. For the discharge day readmission risk, the estimated risk from the 






extreme value 0 or 1 [33]. A pseudo-R-squared value of 0.88 indicates that the beta regression 
model fits the predicted readmission risk well. 
 
Figure 2.1 Results of fitting the predicted readmission risk using a beta distribution.  
 
2.3.3 Unsupervised Clustering Results 
After fitting a beta regression model on the daily readmission probabilities estimated by the first 
stage model using patients-day data as predictors, we used the fitted beta regression model for 
predicting the daily readmission risk. Then, we performed 𝐾 -mean clustering on the daily 






readmission risk trends over time may be seen in Figure 2.2. Four patient groups with different 
readmission risk trends were identified. The trends over 5-days (at 6 a.m.) with the first probability 
generated at admission and the last at discharge is depicted. We identified four patient groups 
based on unsupervised cluster analyses. The ‘decreasing risk’ cluster had 131 (24.5%) encounters. 
Its average readmission probability decreased from 0.69 at admission to 0.30 at discharge. These 
patients entered the hospital with a relatively high 30-day readmission risk that decreased 
substantially (3 times) by hospital discharge. The remaining patient groups maintained a more 
consistent readmission risk. This included the ‘high risk’ group of 113 (21.2%) encounters with 
average readmission probabilities maintained above 0.75 over their course of care. Alternatively, 
the ‘low risk’ cluster with 113 (21.2%) encounters was admitted with a relatively low 0.39 
probability of readmission that decreased to 0.21 at discharge. The ‘Moderate’ cluster had 177 
(33.1%) encounters and its average readmission probability remained around 0.61.  
We conducted the non-parametric Kruskal-Wallis test to determine whether a predictor is 
discriminative between the four clustering groups. The results show that 18 predictors do not have 
equal means across the four clusters (p < 0.0001). The distribution of these discriminative 









Figure 2.2 Daily readmission probabilities for four clusters of patient encounters. 30-day 
readmission probabilities are shown from admission to day 5 in addition to the patients' 
discharge day. Admission represents the time from when the patients arrived at the emergency 
department to the time when they were admitted. In each plot, the thick black line represents the 
mean 30-day readmission probability for all encounters in that cluster. The error bar represents 






Table 2.3 Summary of discriminative predictors for each cluster, shown as boxplots. These 
predictors were produced by the Kruskal-Wallis test at a significance level of 0.0001. 
Predictor Boxplot 

































































































From Table 3, we can see that most of the discriminative predictors are laboratory test 
predictors of potassium, hemoglobin, sodium, and ALT. The other discriminative predictors are 
diastolic blood pressure and the number of prior hospital visits.  
 Overall, a lower hemoglobin level is associated with higher readmission probability during 
the stay, consistent with the fact that a lower hemoglobin level indicates anemia and increased risk 
of readmission. Larger decreases in potassium and diastolic blood pressure levels are associated 
with a decrease of readmission probability. The minimal potassium level occurring later during 
hospitalization is associated with decreasing readmission probability. Also, lower level of diastolic 
blood pressure and sodium are associated with higher readmission probability.  
 A larger decrease in diastolic blood pressure is associated with a lower readmission 
probability. This probably reflects the condition of patients with diastolic heart failure who have 
an increased diastolic blood pressure [36]. Higher variability, higher maximal and average value 
of diastolic blood pressure are associated with encounters whose readmission probabilities stay 
low, while lower values for these predictors are associated with encounters whose readmission 






 An important discriminative administrative predictor is the number of prior hospital visits. 
Specifically, a higher number of prior hospital visits is associated with a higher readmission 
probability.  
To further investigate how the above discriminative predictors are associated with 
readmission risk patterns, we showed how those predictors change with time within each of the 
four readmission risk groups. As there are many predictors, given limited space, we only showed 
results of the main features we discussed above (hemoglobin, sodium, potassium, diastolic heart 
failure) in Figure 2.3. The results for the complete list of the 17 dynamic discriminative predictors 
are shown in Figure 7.1 in the supplemental material. 
 From Figure 2.3, it’s clear to see that: a lower and decreasing level of HGB is associated 
with higher readmission risk; a lower level of sodium is associated with higher readmission risk; 
a larger decrease of potassium level from admission and minimal potassium level occurring closer 
to discharge are associated with lower readmission risk; a larger decrease of diastolic blood 






























(e) Decrease of diastolic blood pressure level from admission (mmHg) 
Figure 2.3 Change of discriminative predictors values over time from admission to discharge 






2.3.4 Partial Dependence of Predictors 
Next, we show the partial dependence plots for the main predictors discussed above in Figure 2.4: 
hemoglobin, sodium, potassium, diastolic heart failure. Those partial dependence plots match with 
the results we see in the above section. Precisely, a larger decrease of hemoglobin from admission 
is associated with higher readmission risk. As we previously discussed, a low hemoglobin level 
indicates bad patient condition regarding blood oxygen level and was found to indicate higher 
readmission risk. A larger decrease of hemoglobin means a lower level of hemoglobin at discharge, 
leading to higher readmission risk. A higher average value of sodium over patients’ stay is 
associated with lower readmission risk. Unlike hemoglobin, the marginal effect of sodium on 
readmission risk decreases when the level of sodium is on the low or high end of its range of values 
in our patient cohort (120-150 mmol/L). Again, the minimal potassium occurring at a later time of 
the patient’s stay is associated with a lower readmission risk. A larger decrease of diastolic blood 
pressure level is associated with lower readmission risk. These findings seem to indicate that a 
more stable patient condition at discharge is associated with a lower readmission risk, which is 
























(d) Decrease of diastolic blood pressure (mmHg) 
Figure 2.4 Partial dependence plots for the main predictors: hemoglobin, sodium, potassium, 
diastolic blood pressure. 
2.4 Discussion 
We created a two-stage daily readmission risk prediction model for a cohort of patients with a 
primary diagnosis of HF. Further, we used clustering analysis to analyze how the likelihood of 






trends. There are two major contributions to this work. First, we built a daily readmission risk 
prediction model that can be used in practice using a two-stage modeling approach. At the first 
stage, we applied logistic regression model to estimate the counterfactual daily readmission risk. 
At the second stage, we utilized a beta regression model to predict the counterfactual daily 
readmission risk using patients-day data. The fitted beta regression model is used as the final risk 
prediction model. Second, we found predictors that indicate different dynamic readmission risk 
patterns during hospitalization. 
A larger decrease of hemoglobin and diastolic blood pressure is associated with a higher 
readmission probability. Many studies have shown that reduced hemoglobin in congestive heart 
failure patients is associated with increased risk of hospitalization and all-cause mortality 
[20][37][38][39][40][39][41][42][43]. Our study result is concordant with those studies. 
 For BUN, the effect on readmission risk may not be the magnitude of the change, but rather 
the decrease from a high BUN measurement at admission. A higher level of the BUN is associated 
with higher risk of all-cause mortality for decompensated heart failure patients [44]. In addition, 
decreased renal function during hospitalization is positively associated with increased HF 
hospitalizations [45][46]. Those with a larger decrease likely started high. A larger decrease of 







 An odds ratio of 0.1 for the normalized index of minimal potassium means that the 
readmission probability will decrease by 90% if the minimal potassium occurs as the last 
measurement instead of the first measurement, given the other predictors remain fixed. Similarly, 
minimal sodium occurring later during hospitalization indicates a lower readmission probability. 
Moreover, patients’ average sodium levels are negatively correlated with readmission probability.  
 By examining the changes of readmission probabilities over the course of a patient’s 
hospital stay, we discovered distinct readmission risk groups. The clusters provide additional 
insights about the discriminative predictors, which are difficult to detect solely by developing a 
static prediction model. The findings from the clustering analysis are supported by evidence either 
in the literature and our static prediction model. For example, both the literature and the prediction 
model show that number of prior hospitalization is positively correlated with risk of readmission 
[17][47][48][49][50].  
 Several findings regarding the laboratory test predictors have not been reported in the 
literature. These findings provide evidence that temporal patterns of these measurements are 
relevant in predicting the risk of HF patient readmissions. In particular, a higher level of 
hemoglobin, a larger decrease in value of potassium and diastolic blood pressure from admission 
to discharge indicates a lower readmission risk. A higher average value of last three hemoglobin 
measurements, which can be considered as patients’ stability measures close to discharge indicates 






[26]. They found that vital sign instability on discharge is associated with increased risk-adjusted 
30-day mortality and readmission rates.  
 Given these findings, further prospective analyses can be designed around developing 
guidelines such as the following to prevent discharging patients with high readmission risk:  
1. Provide special attention to patients who have prior hospital visits.  
2. Measure the patients’ diastolic blood pressure level immediately after admission and 
immediately before planning to discharge them. Our results suggest that patients have 
a high readmission risk if the last diastolic blood pressure level is abnormal or the 
decrease in patients’ diastolic blood pressure from admission to discharge is less than 
or equal to 4.  
3. Measure the patients’ hemoglobin level immediately before planning to discharge them. 
Check the value of the last hemoglobin measurement and the average value of last three 
hemoglobin measurements. Our results suggest the patients have a high readmission 
risk if the values are lower than normal level. 
4. Measure the patients’ potassium level immediately before planning to discharge them. 
Our results suggest that patients have a high readmission risk if the last potassium 






5. Monitor the trajectory of the following dynamic discriminative predictors: average 
value of last three HGB and sodium, a decrease of potassium and diastolic blood 
pressure level from admission, and normalized time of minimal potassium starting from 
admission. Mark patients whose last three HGB and sodium are low or decreasing and 
whose potassium and diastolic blood pressure level remains high and doesn’t decrease 
as potential high readmission risk patients. 
Even though our prediction model has a relatively high predictive power and is the first to 
have identified the different dynamic readmission risk patterns, there are several limitations, and 
our findings need to be interpreted in the context of these limitations. 
 First, we conducted the clustering analysis of patients’ readmission risk by using 
readmission probabilities under a normalized period of stay. The normalization had its advantages 
in that we could compare readmission probability profiles across patients, but the disadvantage is 
we lose out on details that could help with the prediction. Ideally, we want to perform clustering 
on readmission risk by controlling for the entire duration of their stay. However, this is impossible 
due to different lengths of stay of different patients. One option could have been to use warping 
methods such as dynamic time warping (DTW), which matches two time series and yields a 
minimal distance assuming the two time series only differ in speed. But applying DTW would 
have meant that we could not have interpreted the results in a medical context. Nonetheless, we 






analysis. We believe clustering readmission risk over longer patients’ stays won’t qualitatively 
change our findings as patients’ readmission risk tends to vary less towards later of their stay. 
 Second, we treated each encounter instead of each patient as a sample in our cohort for the 
first stage model. The assumption that our sample is independent and identically distributed (i.i.d.) 
is likely violated because multiple encounters may correspond to one single patient and those 
encounters should be non-independent. For predictive modeling, the i.i.d. assumption is important 
concerning model prediction performance evaluation. As we randomly split data into training and 
test data, we require the sample to be i.i.d. to avoid biased performance evaluation. The reason we 
used encounters instead of patients is twofold: 1) we would lose 10.5% of our current sample if 
we treat each patient as a sample (478 patients and 534 encounters), and 2) we believe it’s okay to 
assume that two encounters from the same patient are independent given that most of our predictors 
are clinical data. We hope an analysis on using data from repeated visits from the same patient for 
predictive modeling becomes an opportunity for future research. Another future study could be a 
different modeling approach such as a longitudinal model that captures the correlation between the 
repeated visits of the same patient. 
 Third, we were not able to exclude planned readmissions from our training data because 
we couldn’t identify them. We were mostly interested in predicting unplanned and avoidable 






training data and affected the training process. To make our prediction tool more useful, we can 
exclude planned readmissions in the future analysis when the data become available. 
Finally, we conducted our analysis of dynamic readmission risk patterns retrospectively. 
A retrospective study is more prone to bias and confounding issues compared to a prospective 
study. A prospective approach should be taken to study the readmission risk patterns over patients’ 
stay in the future. 
 Given these limitations, the difficulty of accurately predicting heart failure readmission in 
general, and the complex nature of the problem itself, we believe studying readmission risk 
requires a more holistic approach than simply analyzing EHR data. We should study many aspects 
of healthcare for heart failure patients, from patient treatment, post-treatment care, to readmission 
intervention strategies as an integrated system.  
2.5 Conclusion  
We applied supervised machine learning algorithms in a two-stage approach and built a daily 
readmission risk prediction model that can be used in practice to predict the risk of 30-day 
readmissions for HF patients. To deal with unknown counterfactual daily readmission risk, we 
applied a logistic regression model trained on encounter data to estimate the counterfactual daily 
risk using patients-day data. A beta regression model is further fitted to the counterfactual daily 






 We conducted clustering analysis and found groups of encounters with different 
readmission risks. We also identified the discriminative features associated with risk of 
readmissions. Notably, we found a lower decrease in value of Potassium and diastolic blood 
pressure, a lower value of hemoglobin close to discharge is indicative of high risk of readmissions. 
These can be used as instability indicators to identify patients with high risk of readmissions. As 
a result, intervention can be provided to these patients before they are discharged. For future study, 
besides collecting more data, we propose that controlled experiments or causal inference can be 
conducted to study the discriminative features and the reasons for readmissions. To improve the 
performance of the prediction model, we also propose to exclude planned readmissions from the 









3 Xerostomia Prediction and Knowledge Discovery 
3.1 Introduction  
Head and neck cancer (HNC) patients are commonly treated with radiation therapy (RT). 
However, the anatomic complexity of this part of the body increases the risk of normal tissue 
injury. Of the spectrum of side-effects due to the injury to organs at risk (OAR) from RT, 
xerostomia arising from parotid and submandibular glands radiation have received significant 
study. With modern intensity modulated radiotherapy, it’s now well established that the mean PG 
and SMG radiation dose is associated with the risk of developing xerostomia [51–54], providing 
an opportunity to modify these radiotherapy techniques in the management of HNC patients. 
Despite these technological advancements, RT-induced xerostomia continues to be a 






induced xerostomia, most existing literature used aggregated or summarized dose features within 
certain organs, such as mean dose, and dose-volume histogram (DVH) features in PG [51–53,55].  
DVH is a histogram that describes the relationship between radiation dose levels and the 
corresponding tissue volumes of a radiation treatment plan. It has been commonly used to describe 
three-dimensional radiation dose in a two-dimensional figure and compare different radiation 
treatment plans. There are two types of DVH figures: differential DVH and cumulative DVH. 
Typically, a cumulative DVH is used to describe the dose distributions. Differential DVH is a 
normal histogram of the dose levels in voxels (volume element), where the y-axis is the number 
of voxels that corresponds to a certain dose level. Cumulative DVH shows the volume in the 
percentage of the entire volume of the target region whose dose level is higher than a certain value. 
From the cumulative DVH, we can derive different dose features such D50, D90, which is the dose 
level that 50% of the volume received no less than. For D90, 90% of the volume received a dose 














(b) A cumulative dose-volume histogram 
Figure 3.1 Example of a different dose-volume histograms and a cumulative dose-volume 
histogram. 
The disadvantage of using summarized dose feature within certain organs is that it loses 
the spatial information for the radiation dose within an organ: different spatial distributions of dose 
within an organ can yield the same mean dose and DVH features.  
On the other hand, the spatial information of dose is the key to understanding the local dose 
effect on xerostomia. Pre-clinical investigations suggest that RT-induced xerostomia may not only 
be related to the PG dosimetry but that the spatial location of the subvolume of the PG that is 






portion of the PG caused not only xerostomia but was associated with salivary function recovery 
in contrast to irradiation of the cranial portion. These investigators have subsequently 
demonstrated that this recovery may be related to the presence of stem/progenitor cells that are 
responsible for the recovery of radiation-induced xerostomia [58]. 
Data mining investigations by our group within our Oncospace informatic infrastructure 
have demonstrated human evidence of the low dose impact of PG radiation [59–61] causing 
xerostomia at 3-6 months. As our head and neck conformal radiotherapy typically utilizes coplanar 
beam arrangements, we hypothesized that this might represent the low dose irradiation of the 
cranial portion of the PG that occurs when the target volume extends more superiorly. Pilot 
investigations by our group suggested that the cranial half of the PG and its dosimetry may be 
more important in causing severe xerostomia in our HNC patients [61].  
To more robustly evaluate the influence of specific subvolumes of the PG and SMG on 
injury and symptoms of severe xerostomia after RT, we applied supervised machine learning 
methods and a radio-morphology approach using voxel-based dose features to predict for parotid-
injury-causing acute xerostomia. Radio-morphology parametrically represents the spatial dose 
distribution within normalized anatomic structures using voxel-based or shaped-based dose 
features, which are consistent across patient cohort [62]. The supervised machine learning method 
ultimately used can learn the influence of spatial dose pattern across organ sub-volumes on 






lower or zero weights to the less predictive regions. We define the spatial pattern of the learned 
weights distributed across voxels as the voxel importance pattern. 
3.2 Methods and Materials  
 
Figure 3.2 The flowchart of the key steps for this analysis. (ROI: region of interest) 
3.2.1 Patients 
Our study population included 427 HNC patients who were treated with parotid-sparing intensity-
modulated RT with curative intent from January 2008 to December 2016 and for whom xerostomia 
scores were available in our database. The data included both single-sided and double-sided neck 
treatments. All patients were seen weekly during radiotherapy for on-treatment visit assessments 






that. All study assessments, including the National Cancer Institute Common Terminology Criteria 
for Adverse Events (CTCAE) xerostomia grading, were performed prospectively at the point of 
care during routine treatment and follow-up visits. The study cohort excludes patients who do not 
have all PG and SMG contoured to ensure complete radiation dose features in these two major 
salivary glands.  
3.2.2 Features 
The features are categorized into two parts: planned radiation dose features, patients’ demographic 
and clinical pathology features. To capture the spatial information of radiation dose explicitly, 
organs are sampled into voxels, and actual dose in the voxels are the radiation dose features. The 
voxels are defined as uniformly distributed points in organs downsampled from the original dose 
grid. Specifically, we used voxel-based dose in PG and SMG. 
Patients’ anatomical structures are spatially different. To obtain consistently identifiable 
dose features for all the patients, we aligned patients’ structures to a common reference frame 
using a deformable registration technique, i.e., the Coherent Point Drift algorithm [63]. Further, to 
consider the factor of tumor location in the dose features, we mirrored the patients’ structures so 
that the spatial relationship of the organs, which we derived the dose features from, is not left 
versus right, but rather ipsilateral versus contralateral relative to the disease side. The framework 






The socio-demographic and clinical pathology features included are gender, race, age, 
attending physician, baseline xerostomia grade, tumor characteristics (TNM stage), chemotherapy: 
yes/no, human papillomavirus (HPV) status: positive/negative, whether feeding tube was used, 
and tumor site. Tumor site was characterized by mapping ICD-9 and ICD-10 diagnosis codes to 
specific site definitions. These features were chosen to capture the basic patients’ characteristics 
and factors that may relate to xerostomia. There is no missing data in continuous features, and 
missing data in categorical features were treated as a new “missing” category. Therefore, no 
missing data imputation was performed for features in our study. 
3.2.3 Outcome Measure 
The primary outcome measure was the CTCAE xerostomia grading at the start of the first follow-
up period, which is three months after RT. We choose to look at xerostomia three months after RT 
as an indication of acute xerostomia caused by radiation-induced injury (as opposed to the 
inclusion of recovery). For supervised predictive modeling, a binary classification problem was 
created by grouping the xerostomia grading into two categories: severe xerostomia if the grade is 
2 or 3 and no/mild xerostomia if the grade is 0 or 1. The prediction target is whether a patient will 
develop severe xerostomia three months after RT. Baseline xerostomia grade was measured either 
before treatment starts or during the first week of treatment. For the patients who dropped out 
before three months post-treatment, last xerostomia measure was carried forward. Patient cohort 






Table 3.1 Patient characteristics (N= 427) at baseline. Summary statistics for continuous variables 
(indicated by ‘*’) include the mean and interquartile range. Summary statistics for categorical 
variables is the count and percentage value. p-value is obtained for the two-sample test. 
Predictor Xerostomia grade ≥  2 at 3 months 
post-RT 
p-value 
No (N=282) Yes (N=145) 
Age* 58.62 (52, 67) 58.47 (53, 64) 0.77 
Gender   0.61 
    Male        210 (74.47%) 112 (77.24%)  
    Female 72 (25.53%) 33 (22.76%)  
Race   0.24 
    Caucasian 196 (69.50%) 113 (77.93%)  
    African American 65 (23.05%) 22 (15.17%)  
    Asian/Pacific islander 8 (2.83%) 7 (4.83%)  
    Other 13 (4.61%) 3 (2.07%)  
Attending physician   0.22 
    1 143 (50.71%) 69 (47.59%)  
    2 58 (20.57%) 28 (19.31%)  
    3 35 (12.41%) 25 (17.24%)  
    4 3 (1.06%) 3 (2.06%)  
    Missing 43 (15.25%) 20 (7.09%)  






    Yes 198 (70.21%) 123 (84.83%)  
    No 84 (29.79%) 22 (15.17%)  
HPV   < 0.01 
    Positive 185 (65.60%) 74 (51.03%)  
    Negative 94 (33.33%) 71 (48.97%)  
    Missing 3 (1.06%)  0 (0%)  
Feeding tube used   0.06 
    Yes 196 (69.50%) 88 (60.69%)  
    No 83 (29.43%) 57 (39.31%)  
    Missing 3 (1.06%) 0 (0%)  
Baseline xerostomia grade   < 0.01 
    0 216 (76.60%) 99 (68.28%)  
    1 63 (22.34%) 33 (22.76%)  
    2 3 (1.06%) 13 (8.97%)  
Primary tumor stage  
(T stage) 
  0.89 
    0 12 (4.26%) 6 (4.13%)  
    1 50 (17.73%) 29 (20.00%)  
    2 66 (23.40%) 44 (30.34%)  
    3 47 (16.67%) 23 (15.86%)  
    4 65 (23.05%) 35 (24.14%)  






Regional lymph nodes stage 
(N stage) 
  0.11 
    0 69 (24.47%) 25 (17.24%)  
    1 33 (11.70%) 25 (17.24%)  
    2 128 (45.39%) 83 (57.24%)  
    3 6 (2.13%) 5 (3.45%)  
    Missing 46 (16.31%) 7 (2.48%)  
Distant metastasis stage 
(M stage) 
  0.51 
    Yes 16 (5.67%) 6 (4.14%)  
    No 229 (81.21%) 132 (91.03%)  
    Missing 37 (13.12%) 7 (2.48%)  
Tumor site   < 0.01 
    Oral cavity 52 (18.44%) 45 (31.03%)  
    Oropharynx 54 (19.15%) 42 (28.97%)  
    Nasopharynx 12 (4.26%) 14 (9.66%)  
    Larynx 54 (19.15%) 17 (11.72%)  
    Other 110 (39.01%) 27 (18.62%)  
 
3.2.4 Prediction Models 
Three supervised machine learning algorithms were applied to our dataset: ridge logistic 






under the curve (AUC) score for each model was compared after fitting each model to our dataset. 
The optimal hyperparameters for those supervised machine learning algorithms were chosen using 
10-fold cross-validation while maximizing the AUC score on the hold-out data. Further, the cross-
validation was repeated 40 times with different random splitting of the training data to ensure the 
learned hyperparameters don’t depend on a specific random splitting of the training data. 
To determine the best model, the voxel importance pattern obtained from each algorithm 
along with the prediction performance was evaluated among the three algorithms.  
3.2.5 Voxel Importance Pattern 
Lasso logistic regression learns a sparse set of features and assigns zero weight to non-important 
features. Ridge logistic regression doesn’t learn a sparse solution but assigns larger weights to 
more important features. The magnitude of the feature weights learned by regularized logistic 
regression combined with hyperparameter tuning using cross-validation indicates the relative 
importance of the voxel-based dose features. Also, the radiation dose in different voxels is all on 
the same scale (average dose ranges from 9.09 Gy to 58.77 Gy), preventing the issue of having 
very different weights due to different feature scales. Therefore, the magnitude of the learned 
weights was used as a measure of voxel importance. The voxel importance indicates how much a 
change in the radiation dose in a voxel affects the probability of the patient developing xerostomia. 
Higher positive voxel importance indicates a larger chance of developing xerostomia if we 






The voxel importance for random forest was measured by computing how much the 
squared error decreased during the training process when partitioning data using a certain feature 
over all trees [31,32]. 
To visualize the voxel importance pattern, we normalized the learned weights from logistic 
regression and relative importance measure from random forest to be in the range of [0,1] and 
linearly mapped the normalized voxel importance onto the three-dimensional PG and SMG 
structure.  
We further checked whether the voxel importance pattern is robust and consistent giving 
sample randomness. We randomly separated the data into five folds and repeated the analysis (the 
learning step in Fig. 1) five times on four folds. Then, the correlation coefficients of weights 
learned from the five analyses were computed. High correlation coefficients indicate that the voxel 
importance pattern is robust and consistent on different random samples. 
3.3 Results  
3.3.1 Acute Xerostomia  
3.3.1.1 Acute Xerostomia Outcome 
For the xerostomia prediction outcome, 145 (34%) patients have xerostomia (grade 2 and 3) three 






the dataset. Last-observation-carried-forward was used to obtain the outcome for these patients. 
Figure 3.3 shows the distribution of xerostomia grade at baseline and three months post-RT. It also 
shows a large portion of patients developed xerostomia post-RT. 
 
Figure 3.3 The distribution of xerostomia grade at baseline and three months post-RT. 
3.3.1.2 Dose Distribution 
Figure 3.4 shows the distribution of mean voxel dose and standard deviation of dose in the total 
942 voxels of the PG and SMG across the patient cohort. The mean dose in voxels ranges from 
9.09 to 58.77 Gy while the standard deviation of dose ranges from 7.81to 24.21 Gy. The ipsilateral 






lowest mean voxel doses. The inferior, posterior portion of the contralateral PG and the two SMG 
have the highest variation of dose, while the anterior, superior portion of the contralateral PG has 
the lowest variation of dose in the patient cohort. 
The pattern of mean voxel dose generated is consistent with the clinical practice whereby 
the dose spectrum decreases more superiorly across the PG. The ipsilateral SMG and the tail of 
the ipsilateral PG typically receive comparable high doses of radiation due to the presence of level 







Figure 3.4 The distribution of radiation dose in parotid glands and submandibular glands across the 
patient cohort. 
3.3.1.3 Model Performance 
After obtaining the radiation dose features, non-dose features, and xerostomia outcomes, the AUC 
score of the ridge, lasso logistic regression, and random forest were evaluated using 10-fold cross-
validation on the obtained dataset. The cross-validation AUC score (out-of-sample score) for ridge, 
lasso logistic regression, and random forest are: 0.70±0.04, 0.67 ±0.04, 0.69 ±0.06 respectively. 
3.3.1.4 Voxel Importance Pattern 
Voxel importance patterns for the three methods were shown in Figure 3.5. Ridge and lasso logistic 






larger than the number of samples, or many features are correlated [7]. However, given highly 
correlated voxel-based dose features, lasso yields only one or few voxels from the predictive 
regions due to ℓ1 -norm regularization. Random forest produces non-stable relative variable 
importance due to randomly choosing correlated features, but ridge logistic regression produces a 
stable solution by shrinking weights of correlated features close to each other [7]. The dimension 
of the voxel radiation dose features is high (over 900 voxels) and much larger than the number of 
patients (427). Moreover, the radiation dose features are highly correlated for voxels that are 
spatially close. It’s likely that there is a region of voxels, instead of single or few voxels, of which 
the dose has the largest influence on xerostomia, and other regions have less but not zero influence. 








Figure 3.5 Voxel importance patterns learned from the three machine learning algorithms where 







Ridge logistic regression also has the best prediction performance. Therefore, ridge logistic 
regression was used to study the voxel importance pattern, which is shown in Figure 3.6. Red 
region represents the most important, and violet represents the least important voxels. The dose in 
different subvolumes in PG and SMG, together all affect xerostomia, but the influence of dose on 
xerostomia varies across different subvolumes. Specifically, the superior, anterior portion of the 
contralateral parotid is the most influential region. The medial portion of the ipsilateral PG is also 
very influential, while the superior portion of the ipsilateral parotid is the least influential region. 
The consistency of the voxel importance pattern obtained from ridge logistic regression 
was tested on five different random samples. The lowest Pearson correlation coefficient among 
the weights learned from the five random samples is 0.85, which indicates that the voxel 









Figure 3.6 Voxel importance pattern from ridge logistic regression. (b): a different visualization of 
the same voxel importance result where voxel importance values that are one standard deviation 
away from the mean were “saturated” to increase the resolution of voxel importance closer to the 






3.3.1.5 Dose Comparison using Statistical Test 
We further compared the dose distribution between the two xerostomia groups. The goal is to 
directly see how different distribution of radiation dose was delivered to the two xerostomia groups. 
First, we visualized the dose distribution of each group and the dose difference between them. 
Second, performing permutation test which is a non-parametric two-sample statistical hypothesis 
test. Figure 3.7 shows the mean dose and standard deviation of dose for the two patients group 
categorized as acute xerostomia group versus non-acute xerostomia group. It shows that the mean 
dose in the submandibular glands and inferior part of contralateral PG is higher for the patients 
who developed acute xerostomia, while the patients who didn’t develop acute xerostomia have a 
higher variation of dose among them in the submandibular glands, ipsilateral PG, and inferior part 
of contralateral PG. The dose difference suggests that the acute xerostomia group patients overall 









(a) Mean dose, acute xerostomia: no 
 
 
(b) Mean dose, acute xerostomia: yes 
 
 
(c) Dose variation, acute xerostomia: no 
 
 
(d) Dose variation, acute xerostomia: yes 







To see the dose difference more clearly, we plotted the mean dose difference between the 
two groups as the mean dose of acute xerostomia group minus the mean dose of non-acute 
xerostomia group shown in Figure 3.8. It shows that the acute xerostomia group, on average, have 
higher dose across the entire parotid and submandibular glands on both ipsilateral and contralateral 
side. A particular higher dose was delivered to the contralateral submandibular gland and inferior 
part of the contralateral PG for the acute xerostomia group. 
 
(a) Side view 
 
(b) Anteroposterior view 
Figure 3.8 Mean dose difference as mean dose of acute xerostomia group minus mean dose of non-
acute xerostomia group. 
  
To quantitatively compare the dose difference between the two groups. We applied 






advantage of permutation test is that, as a nonparametric test, it doesn’t require assumptions on the 
sample distributions, which are often required by parametric tests such as a two-sample t-test. 
Ideally, we need to compute the test statistics for all the permutation samples, which is often 
infeasible for large sample size. A large number of random permutations is often performed to 
obtain the distribution of the test statistics under the null hypothesis. For our study, we randomly 
permutated the samples 10000 times, which yields a significance level as small as 0.0001. The null 
hypothesis for the permutation test is that the radiation dose of the acute xerostomia group and the 
non-acute xerostomia have the same distribution. Thus their mean dose should be the same. Here, 
we performed a one-sided hypothesis test and set the alternative hypothesis as 𝜇𝑎𝑐𝑢𝑡𝑒 𝑥𝑒𝑟𝑜 >
𝜇𝑛𝑜𝑛−𝑎𝑐𝑢𝑡𝑒 𝑥𝑒𝑟𝑜, where 𝜇𝑎𝑐𝑢𝑡𝑒 𝑥𝑒𝑟𝑜 and 𝜇𝑛𝑜𝑛−𝑎𝑐𝑢𝑡𝑒 𝑥𝑒𝑟𝑜are respectively the mean dose for the acute 
xerostomia group and non-acute xerostomia group. The permutation test was performed for 
comparing the mean dose level in each voxel between two groups. The steps for the permutation 
test are: 
1. Compute the actual sample test 𝑡 =  𝜇𝑎𝑐𝑢𝑡𝑒 𝑥𝑒𝑟𝑜 − 𝜇𝑛𝑜𝑛−𝑎𝑐𝑢𝑡𝑒 𝑥𝑒𝑟𝑜 
2. Put the radiation dose in a certain voxel from two patient groups together in an array. 
3. Randomly permute the dose array while keeping the patient group label the fixed. 
4. Compute the mean dose difference 𝑇 =  𝜇𝑎𝑐𝑢𝑡𝑒 𝑥𝑒𝑟𝑜 − 𝜇𝑛𝑜𝑛−𝑎𝑐𝑢𝑡𝑒 𝑥𝑒𝑟𝑜, between two 






5. Repeat steps 2-3 for a large number of times (10000 in our case) and obtains the 
distribution of the test statistics 𝑇𝑖 = 𝜇𝑎𝑐𝑢𝑡𝑒 𝑥𝑒𝑟𝑜𝑖 − 𝜇𝑛𝑜𝑛−𝑎𝑐𝑢𝑡𝑒 𝑥𝑒𝑟𝑜𝑖 , where 𝑖 =
{1,2, … ,10000}. 
6. Compute the p-value as the percentage of permutated samples whose test statistics are 
larger than the actual sample test statistic, i.e. 
∑ 𝐼(𝑇𝑖>𝑡)𝑖
10000
 , where 𝐼  is the indicator 
function. 
Figure 3.9 shows the distribution of test statistics and its actual sample test statistic 
indicated by the red line as results of the permutation test for comparing dose in one of the voxels. 







Figure 3.9 Distribution of test statistics using permutation test and the actual sample test statistic 
for comparing mean dose in two patient groups in one of the voxels. 
 
After performing permutation test for dose in each voxel, we obtained the p-values and 
showed them in Figure 3.10. The voxels in red are the regions where the null hypothesis was 
rejected, and the mean dose is statistically significantly different. Subplots (a) and (b) show that 
the mean dose across the red regions in the parotids and submandibular glands in the acute 






group with a significance level of 0.0002, but we can’t reject the null hypothesis that the mean 





Figure 3.10 Distribution of 1 minus the p-values for comparing the mean dose of acute versus non-
acute xerostomia patient groups. (a): regions where p-values above or equal to 0.0002 were 
highlighted in blue, and p-values less than 0.0002 were highlighted in red. (b): anteroposterior 
view of (a). 
3.3.2 Xerostomia Recovery 
After studying the dose influence pattern on acute xerostomia which was caused by radiation 
injury, we performed the same analysis on xerostomia recovery and sought to compare the results 






effect on xerostomia. We expected the dose influence pattern for xerostomia recovery to be 
different from acute xerostomia. 
3.3.2.1 Xerostomia Recovery Outcome 
To define xerostomia recovery, we took xerostomia grade measurements from three time periods: 
baseline (before or within the first week of treatment start), between the end of the radiotherapy 
and 18 months after radiotherapy, and beyond 18 months after radiotherapy. We took the maximal 
xerostomia grades between the end of and 18 months after radiotherapy as the xerostomia measure 
for the second period. Similarly, we took the maximal xerostomia grades beyond 18 months after 
radiotherapy as the xerostomia measure for the third period. Severe xerostomia was defined as 
xerostomia grade equal to or above two. The patient cohort consists of patients who do not have 
xerostomia grade at baseline and have xerostomia measurements available beyond 18 months after 
radiotherapy. Patients who did not recover from xerostomia was defined as whose xerostomia 
pattern over the three time periods is 0\1\1, where 0 represents no severe xerostomia and 1 
represents severe xerostomia. The xerostomia pattern for recovered patients is 0\1\0. We treated 
the xerostomia recovery prediction problem as a binary classification problem as well.  
The total number of patients in this recovery study cohort is 146 (non-recovered/recovered: 
32/114). The same set of voxel dose features and non-dose features as the initial acute xerostomia 






3.3.2.2 Dose Distribution 
 
(a) Mean dose 
 
(b) Standard deviation of dose 
Figure 3.11 The distribution of radiation dose in parotid glands and submandibular glands across 
the xerostomia recovery patient cohort. 
 
Figure 3.11 shows the distribution of mean voxel dose and standard deviation of voxel dose in the 
PG and SMG across the xerostomia recovery patient cohort. The mean dose in voxels ranges from 
8.66 to 67.19 Gy while the standard deviation of dose ranges from 4.84 to 21.22 Gy. The ipsilateral 
SMG has the highest mean voxel doses and the anterior, superior portion of the two PG has the 
lowest mean voxel doses. The inferior, posterior portion of the contralateral PG and the superior 
portion of ipsilateral PG have the highest variation of dose, while the anterior, superior portion of 






 The distribution of mean dose for recovery cohort is very similar with acute xerostomia 
cohort, while the acute xerostomia cohort has a much larger variation of dose likely because its 
sample size is three times of the recovery cohort. 
3.3.2.3 Voxel Importance Pattern 
After applying ridge logistic regression model on the xerostomia recovery data, we plotted the 
voxel importance pattern in Figure 3.12. We indeed found that the relative voxel importance 
pattern for xerostomia recovery is different from the pattern for acute xerostomia. The voxel 
importance pattern shows that the dose level in ipsilateral PG is most influential on xerostomia 
recovery, particularly the superior portion of the ipsilateral PG.  
 
 
(a) Side view 
 
(b) Anteroposterior view 






3.3.2.4 Dose Comparison using Statistical Test 
To see if the voxel importance pattern is related to the dose distribution in the two different 
recovery groups, we compared the dose distribution between the two groups by visualizing the 
mean dose and standard deviation of voxel dose for each cohort in Figure 3.13. Subplots (a) and 
(b) show that the non-recovered patients were treated with a higher dose in the superior portion of 
ipsilateral PG on average, while the dose level other regions in the PG and SMG are about the 
same. The non-recovered patients also clearly have higher dose variation in the superior portion 
of ipsilateral PG, which indicates that the recovered patients received a consistently lower dose in 




(a) Mean dose for not recovered group 
 
 








(c) Dose variation for the not recovered group 
 
 
(d) Dose variation for the recovered group 
Figure 3.13 Dose distribution for not recovered patients group versus recovered group. 
 
To more directly see the dose difference between the two recovery groups, we plotted the 
mean dose difference as the mean dose of not recovered group minus the mean dose of the 
recovered group shown in Figure 3.14. It shows that the superior portion of the ipsilateral PG of 
the not recovered group received a much higher dose, while dose in other regions is about the 
same. The dose difference indicates that being able to recover xerostomia is associated with 








(a) Side view 
 
 
(b) Anteroposterior view 
Figure 3.14 Mean dose difference as mean dose of the not recovered group minus mean dose of 
the recovered group. 
 
To quantitatively check if the dose level is statistically significantly different in any voxels 
between the two recovery groups, we performed the one-sided permutation test on all the voxel 
dose for the recovery cohort. The distribution of p-values was shown in Figure 3.15, and it shows 
that the mean dose in ipsilateral PG and superior portion of the contralateral PG is significantly 
different, particularly the dose is higher for not recovered patients, at a significance level of 0.05. 
In other words, we rejected the null hypothesis that the mean dose levels are the same between the 






 This result matches with the voxel importance pattern obtained using ridge logistic 
regression on xerostomia recovery. They both indicate that higher dose in the ipsilateral PG, 
particularly the superior portion, is associated with higher probability of not being able to recover 
from xerostomia.  
 The voxel importance pattern for recovery is more symmetric than the pattern for acute 
xerostomia. However, both voxel importance patterns show that dose in PGs, especially the 
superior portion is most influential on xerostomia, while the SMGs are relatively not influential. 
We will discuss in detail what the different voxel importance patterns implicate and how they 












Figure 3.15 Distribution of 1 minus the p-values for comparing the mean dose of not recovered 
versus recovered from xerostomia patient groups. (a): regions where p-values above 0.05 were 
highlighted in blue. (b): distribution of 1 minus p-values. (c): anteroposterior view of (a). (d): 
anteroposterior view of (b). 
3.4 Discussion  
The results presented demonstrate the successful application of the use of spatially explicit 
radiation dose features in predicting xerostomia in HNC patients, leading to the identification of 
important parotid dose subvolumes associated with the risk of severe xerostomia at three months 
following radiotherapy. To the best of our knowledge, this analysis used the largest xerostomia 
HNC patient cohort in literature, which enables robust modeling results and conclusions. The 






to radiation-induced xerostomia as initially proposed in humans by van Luijk et al. [57]. Modeling 
the radiation dose spatially explicitly provides insights into the spatial dependence of dose in 
contrast to the use of DVH features alone. For instance, we are aware of one existing study that 
used a similar voxel-based dose analysis for acute dysphagia in HNC patients [66]. The authors 
applied a statistical test to compare the voxel-based dose distribution between patients with grade 
>= 3 versus with grade <3 dysphagia. In contrast, we combined voxel-based dose modeling with 
supervised machine learning algorithms to build a predictive model for xerostomia and also 
learned how spatial dose influences xerostomia, highlighting the flexibility of this methodology. 
This also demonstrates that our methodology can be applied to other radiotherapy-related head and 
neck toxicities such as dysphagia and trismus.  
The distribution of average dose shows that the most important region found for acute 
xerostomia, i.e., the superior, anterior portion of the contralateral parotid, is within the low dose 
region in the patient cohort. This is consistent with results from our prior studies using DVH 
features which demonstrated the impact of a low dose bath to both PG on the risk of grade >=2 
xerostomia [59]. We believe if this region is treated with high radiation dose, it’s likely that the 
other regions were treated with even higher dose, leading to a much higher risk of developing 
xerostomia. Further, we would expect the superior portion of ipsilateral PG also to be more 
predictive as it’s also a low dose region. However, the voxel importance pattern result is not 






that in the ipsilateral PG, the medial portion is more important because it’s very close to the ductal 
region. Radiation damage to this medial portion will render dose in the superior portion much less 
important in predicting xerostomia. This matches the hypothesis that we may have damaged the 
duct responsible for transporting saliva for the patients that received a high dose in that region. 
The voxel importance pattern for xerostomia recovery shows that the dose level in 
ipsilateral PG is most influential on xerostomia recovery, particularly the superior portion of the 
ipsilateral PG. The superior portion of contralateral PG is relatively important on the contralateral 
side. The superior portion of the ipsilateral PG is also the low dose bath region in the recovery 
cohort. However, the machine learning algorithm is not simply identifying the low dose bath 
region as the most influential region as the support portion of the contralateral PG has the lowest 
mean dose but the algorithm didn’t identify that region as most influential. 
For both voxel importance patterns, the machine learning algorithm didn’t exactly identify 
the low dose bath region as the most influential region regarding dose effect on xerostomia. Neither 
of the voxel importance patterns is symmetric, which is likely caused by the non-symmetric dose 
distribution delivered across the ipsilateral and contralateral PGs. Combing the two voxel 
importance patterns, we can see it’s clear that dose in the PGs is more influential than the dose in 
the SMGs for our cohort. We hypothesize that this can be caused by two reasons. First, the dose 
in SMGs is influential on xerostomia. The reason that the algorithm didn’t identify SMGs as 






especially the ipsilateral side. Even though for acute xerostomia study, acute xerostomia patients 
received statistically significant higher dose than non-acute xerostomia patients and there is 
enough variation of dose in SMGs, we believe that the dose variation won’t have a differential 
effect on xerostomia outcome if the dose is very high and exceeds a certain threshold. In other 
words, we expect the dose effect on xerostomia to be nonlinear and is diminishing when it exceeds 
a certain high threshold. Second, the dose in the SMGs may indeed have a very limited effect on 
xerostomia outcome. 
On the other hand, the PGs received a relatively lower dose on average for our cohort, and 
the dose variation in PGs was shown to have a larger differential effect on xerostomia outcome. 
This was well explained, particularly, by the xerostomia recovery analysis. The superior portion 
of ipsilateral PG was identified as the most influential region by the machine learning algorithm. 
The dose distribution in the two recovery groups shows that region has the largest mean dose 
difference as high as 14 Gy, while all the other regions have about zero mean dose difference. This 
region is also in the low dose bath region on the ipsilateral side. The pattern of mean dose 
difference of the xerostomia recover cohort is much simpler than the pattern of the acute 
xerostomia cohort, and it makes it much easier to see how the influential region identified by the 
machine learning algorithm is related with the dose distribution. 
Overall, the results from acute xerostomia and xerostomia recovery show that the dose in 






on developing xerostomia. Besides, higher dose delivered across the PGs and SMGs are associated 
with more severe xerostomia (both acute and long-term). However, the findings are specific to our 
cohort and affected by the limited dose variation in the cohort. This highlighted the challenge that 
it’s difficult to identify the causal effect of level of the dose delivered to organ subvolumes on 
xerostomia using observational study. It also highlighted the complexity of the dose-effect and 
potential spatial dependency of dose-effect across organ subvolumes. For instance, we would 
expect the dose effect on xerostomia in the PGs to be more or less symmetric, but our results didn’t 
reveal this in each xerostomia analysis, which is, again, likely caused by the specific dose 
distribution for each study cohort.  
The findings provide insight into the importance of bilateral parotid injury and underscore 
the importance of carefully determining the clinical indications for bilateral cervical nodal 
irradiation along with a careful delineation of how superior and lateral the cervical nodal planning 
target volumes encroach upon the medial and superior aspects of the PG. Moreover, the analysis 
also demonstrated to a lesser degree, the importance of the subvolumes in the contralateral SMG 
contributing to the severity of the xerostomia at three months post-RT. This highlights the clinical 
implications and importance of reducing the volume of cervical neck irradiation as a clinical 
strategy to de-intensify the current chemoradiation treatment paradigms for head and neck 






Several additional limitations of our analysis need to be recognized. First, the study 
population consists of patients treated in a single local hospital. The specific voxel importance 
pattern obtained with the algorithmic modeling may be valid only for specific patients and specific 
dose distribution planned at this hospital. Second, for acute xerostomia prediction outcomes, we 
used last-observation-carried-forward to obtain the data for patients who dropped out before three 
months post-RT. Our longitudinal xerostomia outcomes data show that there is minor xerostomia 
recovery from the end of treatment to three months post-RT. Therefore, our prediction outcome 
data could be slightly biased towards a more severe xerostomia grade. Third, the pattern of dose 
effect on xerostomia we learned in this study represents only association or correlation between 
radiation dose and xerostomia. As most patients have similar patterns of dose, it is challenging to 
evaluate dose-response outside of the range of patterns delivered to patients in the database. No 
conclusion on the causal effect between dose and xerostomia was established in this observational 
study. Finally, this study only included radiation dose in PG and SMG, while there is a study 
reported the mean dose to oral cavity is associated with xerostomia as well [51]. 
For future studies, we are going to apply this approach to HNC patients in other hospitals, 
which have different patient characteristics and radiation treatment plans to validate our approach 
and the voxel importance pattern we learned. Ultimately, we want to learn causal effect between 
radiation dose and xerostomia, which is difficult using observational studies. Either experimental 






causal inference technique, i.e., causal sufficient dimension reduction, for high dimensional 
treatments problems [67], which we are currently applying to our problem. Finally, we will also 
include dose in the oral cavity in our study to investigate how dose in subvolumes in the oral cavity 
is associated with xerostomia. 
3.5 Conclusion  
We have identified that dose to the specific subvolume in the PG and SMG, i.e., the superior, 
anterior portion of the contralateral PG is most predictive of acute xerostomia and superior portion 
of ipsilateral PG is most predictive of xerostomia recovery. Those influential regions all lie within 
the low dose bath region in our study population. We also found the medial portion of the ipsilateral 
PG to be predictive of acute xerostomia. We believe our methodology and the local dose effect 










4 Wood Chip Trade Response to Renewable Energy 
Policies 
4.1 Introduction  
The U.S. Renewable Fuel Standard (RFS) mandates blending of biofuel in road gasoline and diesel 
[68]. The mandated volumes of biofuel are scheduled to increase every year to 2022, and cellulosic 
biofuel made from non-food feedstocks is the fastest growing component of this mandate. 
Although actual production of cellulosic biofuel has consistently fallen below mandated volumes 
in every year of the RFS program, commercial-scale cellulosic biofuel facilities continue to be 
built utilizing a wide range of feedstocks. Environmental Protection Agency (EPA) has approved 






including perennial grasses like miscanthus and switchgrass, agricultural residues like corn stover, 
and forestry residues [68]. The agency is considering expanding this list to include pulpwood from 
whole trees [69], which, if approved, could lead to increased demand for wood harvests. U.S. 
consumption of wood for electricity has been rising since 2009 [70]. At the same time, the EU’s 
Renewable Energy Directive is driving very high imports and consumption of wood pellets [71], 
which are produced from wood chip and other pulpwood product. The EU has been increasingly 
dependent on biomass import for energy. Its total imports of wood chip both for energy and pulp 
production have increased from 6 million cubic meters in 1997 to 16 million cubic meters in 2011 
according to the FORESTAT database [72]. Wood pellets were identified to be efficient to be used 
for co-firing to generate renewable electricity in Germany and Austria [73]. However, co-firing 
coal with wood pellets is currently not economically feasible within the U.S. due to the recent U.S. 
natural-gas boom [74].  
With these two policies working together to drive up demand for wood harvests, where 
will the additional supply come from? The answer is important to understanding the lifecycle 
environmental impacts of the potential pulpwood to biofuel pathway under the RFS. Some 
additional supply would very likely come from the Southeastern U.S. where most American 
pulpwood is produced. However, due to the EU’s phytosanitary measures [75], US’s export of 
softwood chip to the EU has been very limited because of the existence of nematodes in US’s 






instead. If the additional wood is produced from new forestry plantations on previously unforested 
land, cellulosic biofuel could deliver significant carbon savings. If on the other hand, the increased 
wood supply comes from existing forests in countries with weak forest protection policies and 
enforcement, a pulpwood biofuel pathway in the U.S. would likely cause a net increase in 
emissions compared to fossil gasoline or diesel [76].  
Most previous studies about wood bioenergy markets were conducted at the country level, 
specifically for European countries such as Austria, Norway, Italy, and Poland. Those studies in 
general focus on three aspects: first, bioenergy potential of a certain region; second, demand, 
supply and production of certain bioenergy; and third, bioenergy usage in a certain country. For 
example, Nilssona et al. analyzed the status and potential of bioenergy in Poland in 2006 and found 
that firewood for heating was the main bioenergy usage [77], which consisted of 95% of renewable 
energy usage in 2003. Nilssona et al. concluded that Poland’s bioenergy market and policy were 
undeveloped even though it had a large potential for bioenergy [77]. Paiano et al. estimated the 
bioenergy potential in Italy and found 2.7% of the gross Italian energy consumption in 2013 could 
be generated from residual biomass, which could save about 52 Mt CO2eq emission for Italy per 
year [78]. Trømborg et al. analyzed the effect of various bioenergy policies on the usage of forest-
based bioenergy in Norway using a spatial partial equilibrium model and found the share of 
bioenergy in the Norwegian energy market was much lower than other EU countries due to low 






subsidies, deposit grant, and feed-in systems could significantly increase Norway’s bioenergy 
production. Trømborg et al. also gave a detailed presentation of the forest biomass potentials for 
heating in Norway in 2011 and concluded it is unlikely the government target of 14 Twh more 
bioenergy by 2020 can be met [80]. Also, those studies mainly focused on wood pellets but not 
wood chip.  
Few studies have been done about the international trade of wood bioenergy, especially for 
wood chip. One study presented an overview of the historical international trade flow, bioenergy 
policies and market factors for solid biofuel such as wood pellet, wood chip, and roundwood in 
main markets including the EU, North America, Russian Federation, and Japan [81]. They 
identified that wood pellets had become the most traded solid biofuel as a globally traded 
commodity and its trade increased from 8.5 PJ to 120 PJ from 2000 to 2010. Another study 
reviewed the market factors and policies for global wood pellet market and presented the 
opportunities and challenges for the wood pellets industry [82]. They expected that the EU would 
remain the main wood pellets market and East Asia’s market would be further expanded. The only 
study on global wood chip trade for energy was done by Lamers et al. [75]. They presented the 
historical global trade data of wood chip and estimated that energy-related wood chip trade volume 
was less than 10% annually. Also, they identified that the key constraint of trading wood chip for 






wood chip trade data. Building on this data, our study takes a further step and analyzes the wood 
chip trade changes under different EU and U.S. renewable energy policy scenarios. 
Junginger et al. also identified logistics including transportation as the major barrier for 
solid biomass commodities due to their low energy density and a relatively low value [83]. A 
recent financial analysis of the transport of wood chip from the USA to Germany estimated that 
transporting wood chip per weight is more than twice as expensive as transporting wood pellets 
because wood pellets have a much higher density [84]. 
In addition, phytosanitary requirements are another barrier to the trade of wood chip that 
is infected by insect pests. For example, export of softwood chip from the US to the EU was 
restricted due to the EU’s phytosanitary requirement regarding wood chip as previously 
mentioned. 
The main contribution of this study is we build the first global trade model for wood chip 
and analyze how local energy policy from U.S. and EU will affect the global market for wood 
chip. Specifically, we find that wood chip exports from tropical regions would increase 
significantly. Implementation of sustainability criteria for biomass should focus on these regions. 
To ensure the imported biomass feedstock is sustainable, EU has initiated the BioTrade2020plus 
project. Iriarte et al. suggested the sustainability criteria and assessed the sustainability risks for 
biomass including wood chip focusing on current and potential future major sourcing regions 






cost of wood chip using positive mathematical programming, an automatic calibration technique 
that has been extensively used to overcome limited availability of trade data and supply data. 
Also, our analysis can be a springboard towards deeper analysis by including other policy, 
environmental and technical factors such as the implementation of sustainability criteria, 
technology changes, and forest growth. 
4.2 Methods and Materials  
4.2.1 Data Preprocessing  
The wood chip trade data were downloaded from the FORESTAT database [72]. The commodity 
extracted from this database was “wood chip and particles.” The data included the quantity and 
value of wood chip traded between countries. Quantity was measured in cubic meters and value 
was measured in thousands of U.S. dollars. Export values are reported as free on board value while 
import values consist of cost, insurance, and freight, according to the Food and Agricultural 
Organization of the United Nations (UN FAO) [86]. 
It’s important to note that the wood chip trade data we used is the entire trade of wood chip, 
not solely the bioenergy-related wood chip trade. We didn’t separate the wood chip trade data 
based on its end-use, i.e., used for bioenergy or paper production, for three reasons. First, our goal 
is to analyze the changes of wood chip trade due to renewable energy policies. Our goal is not 






chip trade based on its end-use. For example, in 2006, Hillring analyzed the trade patterns for forest 
product and wood fuel [87]. For wood fuel, Hillring’s analysis focused on charcoal trade. Wood 
chip trade data was presented in the analysis but not categorized based on its end-use. Later in 
2012, Lamers et al. estimated that annually reported energy-related wood chip trade volumes were 
less than 10% based on anecdotal evidence, literature review and personal assumption, for 
example, assuming global trade of wood chip for energy was exclusively towards the EU [81]. We 
believe wood chip traded for paper production (pulpwood) can also be used for bioenergy. For 
example, as Olsson and Hillring mentioned, in 2009, the global financial crisis reduced demand 
for pulpwood from Swedish pulp & paper producers, which led to the excessive export of 
pulpwood for energy to Denmark [88]. Therefore, we modeled the entire demand and supply of 
wood chip, but our scenarios only modeled changes in policies from energy and changes in energy 
policy result in absolute changes in wood chip consumption globally. Second, there is no trade 
data currently available for wood chips used for bioenergy in international statistics because 
current six digits international trade code for wood chip doesn’t differentiate by end-use. Third, 
indirect trade of woody biomass makes it further complicated to separated energy-related wood 
chip trade from wood chip traded for pulp and paper production. For instance, for the Kraft pulp 
production, part of the pulpwood is used to produce heat in the pulp mills [89][90]. This part of 
pulpwood was not explicitly traded for energy but still ends up in energy production. Therefore, 






The dataset contains both volume and prices for wood chip between countries. This country 
level dataset provides us the flexibility to do analysis both at the country level or aggregated 
regional level. However, there were some discrepancies in the raw data from year to year. For 
example, the main discrepancy in quantities was that imports and exports between countries did 
not match. Various reasons exist for trade data discrepancies. For example, country A’s exports 
could arrive at country B the following year, leading to total exports not matching total imports 
for the year. Moreover, some exporters may underreport to reduce tariff costs. It could also be 
caused by data entry errors. To deal with this data discrepancy, we first aggregated the data from 
all countries into 14 regions. Aggregating the data into 14 regions reduced the discrepancy because 
many discrepancies, for example, within a region canceled out with each other after aggregation. 
At the same time, we only considered trade between regions and ignored trade within a region. We 
chose to use the year 2011 data for our analysis, which are the most recent data available with 
relatively small data discrepancy compared to other years. In the end, we only used export data 
because the data discrepancy may have resulted from importers reporting less to reduce import 
duties. Table 4.1 displayed the list of the countries aggregated into each region, the total exports 










Table 4.1 Total exports and imports of wood chip for each region in 2011. Trade quantity was 
measured in cubic meters. The column ‘Countries’ contains the countries that were aggregated 
into its corresponding region. The total exports and imports for a region is the sum of the exports 
and imports from all the countries in that region. 






Central America Bahamas, Barbados, Belize, Costa Rica, 
Dominican Republic, Guatemala, Haiti, 






East Asia China, Democratic People’s Republic of Korea, 




European Union Austria, Belgium, Croatia, Cyprus, Czech 
Republic, Denmark, Estonia, Finland, France, 
Germany, Greece, Hungary, Ireland, Italy, 
Latvia, Lithuania, Luxembourg, Malta, 
Netherlands, Poland, Portugal, Romania, 














Armenia, Azerbaijan, Belarus, Georgia, 
Kazakhstan, Kyrgyzstan, Republic of Moldova, 






Latin America Argentina, Bolivia, Brazil, Chile, Colombia, 
Ecuador, Guyana, Paraguay, Peru, Suriname, 






Middle East Bahrain, Iran (Islamic Republic of), Israel, 
Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi 













Oceania Australia, Fiji, French Polynesia, New Caledonia, 
New Zealand, Papua New Guinea, Solomon 






Other Europe Albania, Bosnia and Herzegovina, Iceland, 

















Southeast Asia Cambodia, Indonesia, Philippines, Singapore, 








Burkina Faso, Cameroon, Congo, Côte d'Ivoire, 
Democratic Republic of the Congo, Ethiopia, 
Gambia, Ghana, Guinea, Liberia, Madagascar, 
Malawi, Mauritius, Mozambique, Nigeria, 
Rwanda, South Africa, Togo, Uganda, United 






USA USA 5,659,235 129,435 
 
A caveat of our data input is that we didn’t explicitly consider the bioenergy potential for 
each region, for example, the forest growth in the US. Instead, our data input is the export and 
import of wood chip for each region. The reason is that we are not trying to predict whether a 
region can satisfy the EU’s demand for wood chip as bioenergy. Instead, we are trying to predict 
how the global trade of wood chip would change under various scenarios. Knowing the bioenergy 
potentials alone would not inform those changes of trade. For example, we believe that our results 
will not be affected even considering the forest growth in the US due to EU’s phytosanitary 
measures. The EU’s requirements for phytosanitary measures have significantly limited the trade 
of softwood chip from the US to the EU. In fact, our model took this effect into account through 






exported 64 thousand cubic meters wood chip to the EU, which is only 1% of the US’s total export 
of wood chip in that year. Thus, wood chip from the US’s forest growth is unlikely to satisfy EU’s 
demand of bioenergy given EU’s phytosanitary measure unless the US can eradicate nematodes in 
its wood chips in the future. Nonetheless, as we will later discuss in the discussion section, 
estimating the sustainable bioenergy potential will help inform us whether deforestation will 
happen or not. 
The difference between export values and import values should include the transportation 
cost, but due to some issues with valuing freight transportation costs such as time lag and customs 
tax avoidance [84], we needed to calibrate the transportation cost within the model to achieve 
results that matched reality. Calibration was a natural solution to this problem as transportation 
cost plays a significant part in the trade of wood chip [84]. 
4.2.2 Mathematical Model 
4.2.2.1 General Model Framework 
As mentioned previously, EPA is considering whether to approve pulpwood from whole trees to 
be used as bioenergy that is eligible for RFS support. Meanwhile, the EU’s Renewable Energy 
Directive is increasing the demand for wood bioenergy for heat and power generation in the EU. 






application problem and based on the literature review we conducted, we chose to use the spatial 
price equilibrium model (SPE) and the FAOSTAT data previously described. 
We adapted the static SPE to model the global wood chip trade flow for one year [91][92]. 
Since Samuelson presented the equivalence between SPE and linear programming theory, SPE has 
been used for modeling regional and international trade in food and forest sectors [93]. Lauri et al. 
applied a partial equilibrium model which is based on an SPE model to estimate the biomass energy 
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 ≤ 𝑆𝑖 
𝑆𝑖, 𝐷𝑖 , 𝑥𝑖𝑗 ≥ 0,  ∀𝑖, 𝑗 
(4.1) 
Samuelson defined the objective function as “net social payoff.” The first term, second 
term and third term in the objective function respectively represents the consumers’ utility, 
production cost, and transportation cost. The constraints represent the trade flow conservation. 
Subscript 𝑖 represents demander 𝑖 and 𝑗 represents supplier 𝑗. Please see Table 4.2 for description 






demand prices as the dual variables for the demand constraints, and supply prices as the dual 
variables for the supply constraints.  
Table 4.2 Model variables and parameters. This table contains the list of variables and parameters 
used in our model and their descriptions. 
Symbol Description 
𝑥𝑖𝑗 trade flow from region 𝑖 to region 𝑗 
𝐷𝑗  demand at region j 
𝑆𝑖 supply at region 𝑖 
𝜃𝑖(𝐷𝑖) demand function at region 𝑖 
𝑃𝑗(𝑆𝑗) supply function at region j 
𝑐𝑖𝑗 unit transportation cost from region 𝑖 to region 𝑗 
𝐸𝑠,𝑗,𝑘 price elasticity of supply for region k in year j 
𝑆𝑗,𝑘 supply quantity of wood chip for region k in year j 
𝑃𝑗,𝑘 supply price of wood chip for region k in year j 
𝑆2011,𝑘 supply quantity of wood chip for region 𝑘 in year 2011 
𝑃2011,𝑘 supply price of wood chip for region 𝑘 in year 2011 








4.2.2.2 Model Details 
In this section, we describe the details of our underlying model as well as the implications for our 
adaptation of the general SPE model. While our assumptions are necessary for a global trade 
analysis given insufficient data, we justify our approach using available evidence and provide 
information on how the results can change if we had more detailed data.  
First, we assumed perfectly inelastic demand for wood chip for our policy analysis. Our 
study focuses on how supply would be affected by increased demand. So, for our policy scenario 
analysis, it makes sense to fix demand but not supply and adjust demand for different policy 
scenarios. While there is no previous study about the demand elasticity of wood chip, Kristöfel et 
al. found the demand for wood pellets in Austria to be inelastic in the short run using a two-stage 
least squares regression. Our assumptions are consistent with this result [95]. 
Second, we assumed a linear supply curve. For a perfectly competitive market, the supply 
curve is equivalent to the upward-sloping part of marginal cost curve where the marginal cost is 
larger than the supplier’s average variable cost [96]. Therefore, for a linear supply curve, the 
change in marginal cost is constant as production increases. However, if we use a quadratic supply 
curve, the change in marginal cost would increase as production increases. The total production 
cost could be much higher if we used quadratic supply curve at higher levels of production. 
Normally this is because of limitations of technology and the increasing cost of extracting a 






production capacity in any one region during the year, a linear approximation to the supply curve 
is justified. More data would have allowed us to determine the functional form better, but a linear 
supply curve captures the dynamics of supply for one year. We constructed our supply curve using 
arc supply elasticities, reference supply, and reference supply price based on our data as described 
in detail in the Model Construction section. There are no comprehensive studies about supply 
elasticity of wood chip.  
Finally, we represented transportation cost as a quadratic function of the traded amount of 
wood chip. A quadratic transportation cost function means the marginal transportation cost is 
increasing linearly. Intuitively, this makes sense, as the total amount of wood chip transported 
increases, the unit price of transporting unit amount of wood chip will increase due to reasons such 
as the shipping vessels reaching capacity. A quadratic transportation cost also implies there is an 
optimal amount of wood chip to transport, which occurs when the corresponding excess marginal 
transportation cost is zero. A marginal transportation cost of zero means it is the most cost-effective 
to transport that amount of wood chip. In conclusion, a quadratic transportation cost function 
allows for a good representation of increasing marginal costs while still allowing for analysis and 
calibration. 
Given above assumptions, the first term in the objective function of the general SPE model 
became constant and can be ignored since we used perfectly inelastic demand, i.e., the demand is 






demand. Then we only need supply functions 𝑃𝑖(𝑆𝑖) and transportation costs 𝑐𝑖𝑗 to construct the 
model as described in the next sections. Furthermore, we assumed the supply curve is linear and 
transportation cost is a quadratic function of trade quantity of wood chip. So, the supply function 
𝑃𝑖(𝑆𝑖) is a linear function and a quadratic term for the transportation cost would be added to the 
objective function in model (4.1) in the model construction section. Table 4.2 contains the list of 
variables used in our model and their corresponding descriptions. 
4.2.2.3 Model Calibration 
The goal of calibration is to choose model parameters so that the outputs exactly match or are as 
close as possible to the observed data. In our case, the transportation cost parameters were perfectly 
calibrated using 2011 wood chip trade data, to ensure that the factors determining transportation 
costs are embedded in the calibrated parameters. This includes any contracts, taxes, and other cost 
components of transporting wood chip. Model calibration is a type of parameter estimation and is 
also called inverse optimization. Several previous studies solved inverse linear programming 
problems for purposes of calibration [98][99][100]. 
We used the positive mathematical programming (PMP) approach for our model 
calibration [101]. PMP calibrates parameters perfectly, and the calibrated model will produce the 
same solution as observed data. It has been mainly applied to policy analysis and studied in the 
field of agricultural economics [102]. PMP is a two-stage process. In the first stage, we solved the 






constructed parameters using duals from the first stage problem and observed data. We added 
another nonlinear term to the objective function in stage 1 using the constructed parameters to 
form the objective function for the stage 2 problem. The constraints are the same for two stages. 
The model at stage 2 will give a solution that is the same as the observed data [103].  
4.2.2.4 Model Construction 
4.2.2.4.1 Overview 
We build our final calibrated SPE model in two steps. First, we calibrated the transportation cost 
of a basic linear programming transportation model. Then, we added production cost to the 
calibrated model and relaxed the fixed supply constraints. The detailed model construction 
proceeds as follows: 
4.2.2.4.2 Linear programming transportation model 
When demand and supply are constant, then SPE model is equivalent to a linear programming 




𝑠𝑢𝑏𝑗𝑒𝑐𝑡 𝑡𝑜                                   
𝐴𝑥 ≤ 𝑏 (𝑑𝑢𝑎𝑙𝑠 ?̂?) 







𝑤ℎ𝑒𝑟𝑒 𝑥 ∈ ℜ𝑛, 𝐴 ∈ ℜ𝑚×𝑛, 𝑏 ∈ ℜ𝑚, 𝑐 ∈ ℜ𝑛, ?̂? ∈ ℜ𝑛 
Here, 𝑛 = 196, 𝑚 = 28 for the entire model. The symbols 𝑐 ($/𝑚3) are the unit transportation 
costs of wood chip between regions. Since we do not have perfect transportation cost data, we start 
with using export prices as 𝑐 for the linear part of the transportation cost function that we will 
calibrate. The parameter 𝑏 represents the wood chip supply and demand for all the regions. Denote 
?̂? as the dual variables for the constraints at the optimal point.  
Define parameter  𝛾 ∈  ℜ𝑛 as: 
 𝛾 =  −𝑐 − 𝐴𝑇 ?̂? (4.3) 
The goal is to find a constant vector 𝛼 ∈ ℜ𝑛 such that:  
 𝛾 − 𝛼 > 0 (4.4) 
Define parameter Γ ∈ ℜ𝑛×𝑛 as a positive definite diagonal matrix: 
 
Γ = 𝑑𝑖𝑎𝑔 [
( ?̂?1 − 𝛼1)
?̂?1
, … ,
( 𝛾𝑖 − 𝛼𝑖)
?̂?𝑖
, … ,
( 𝛾196 − 𝛼196)
?̂?196
] (4.5) 
where ?̂? is the observed wood chip trade flow. 







𝑥𝑇Γ𝑥 − 𝛼𝑇𝑥 
                     𝑠𝑢𝑏𝑗𝑒𝑐𝑡 𝑡𝑜 







𝑥 ≥ 0    
𝑤ℎ𝑒𝑟𝑒 𝑥 ∈ ℜ𝑛, 𝐴 ∈ ℜ𝑚×𝑛, 𝑏 ∈ ℜ𝑚, 𝑐 ∈ ℜ𝑛  
When Problem ((4.6) is solved, 𝑥 = ?̂? and 𝜆 = ?̂?. This can be proven by looking at the problem’s 
optimality conditions. 
4.2.2.4.3 Add supply function and relax fixed supply 
Add supply functions to the objective function and relax fixed supply in the constraint. We first 
estimated arc elasticities of supply for each region by using the median value of historical arc 
elasticities. We took supply quantity and supply price for the year 2011 as a reference. For each 
region, we compute the arc elasticities for each year since 1996 as the following: 
 










Where 𝑆𝑗,𝑘 and 𝑃𝑗,𝑘 are the wood chip supply quantity and supply price in year 𝑗 for region 𝑘. We 
used US’s historical consumer price index data to correct the export prices for inflation. All the 
prices were adjusted to base on US dollars in year 2011. 
Before calculating the elasticities, we filtered out supply prices which are either below 
$10/tonne or above $200/tonne. We consider supply prices out of this range ($10/tonne to 
$200/tonne) to be outliers. Regions that have supply price outliers comprise less than 20% of total 






outliers are very likely to be incorrect, so to obtain a robust supply elasticity estimate, we excluded 
these price outliers.  
We use the average value of 𝐸𝑠,𝑗,𝑘 as the supply elasticity for that region k which we denote 
as 𝐸𝑠,𝑘.For regions that have negative elasticities, we set their elasticities to be the smallest positive 
supply elasticities among other regions. The estimated supply elasticities are in Table 4.3.  
We constructed a linear supply function for region k using estimated elasticity and 
reference (the year 2011) supply quantity and price: 
 
𝑆𝑘 = 𝑆2011,𝑘[1 + 𝐸𝑠,𝑘 (
𝑃𝑘
𝑃2011,𝑘
− 1)] (4.8) 
The inverse supply function is: 
 






− 1)] (4.9) 
Note 𝑃2011,𝑘 is the supply price for region 𝑘 from the above quadratic programming model i.e., the 
dual corresponding to the supply constraint in the quadratic programming model. By constructing 
such supply functions, we can relax fixed supply constraint and add production cost to the objective 
function without changing the solutions from the calibrated quadratic programming model. 
Another simple approach to construct a linear supply curve is to fit a linear regression curve 
to the supply quantity and price data of wood chip. However, due to an insufficient amount of data 






possible. The availability of more wood chip trade data, for example, monthly data, would help 
produce a more robust linear supply curve using this approach. 
Table 4.3 Estimated wood chip supply elasticities for each region 
Region Supply Elasticities 
Central America 0.27 
Canada 1.85 
East Asia 0.27 
European Union 2.76 
Former Soviet Union 5.56 
Latin America 4.58 
Middle East 0.27 
North Africa 0.27 
Oceania 0.39 
Other Europe 1.10 
South Asia 0.27 
Southeast Asia 5.30 
Sub-Saharan Africa 0.57 
USA 0.27 
 
4.2.2.4.4 Final SPE model 
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The objective function is minimizing the production cost plus transportation cost, the same as 
maximizing the negative value of the production cost plus transportation cost. Subscript i 
represents region i and j represents region j. The equality constraint means the total imports into 
region j equals to region j’s demand. The inequality constraint means the total exports from region 
j can’t exceed its supply. The detailed description of each model variable is in Table 4.2. 
We considered two types of scenarios: first, the U.S. decreases its supply to other countries 
to satisfy its increasing domestic demand for cellulosic biofuel and biomass electricity, and second, 






upper bound for the U.S.’s supply. We obtained the upper bound by reducing the U.S.’s supply for 
the base case by the projected amount, which is the U.S.’s increased demand for that scenario. For 
the second type of scenario, we simply increased the EU’s demand to the projected level. For each 
type of scenario, there are different levels of demand and supply given by our projections for the 
year 2022.  
Our projections are based on expected outcomes from two major policies: the EU’s 
Renewable Energy Directive (RED) and the U.S. Renewable Fuel Standard. The first policy 
incentivizes biomass heat and power as a compliance option for EU’s renewable energy mandate. 
The U.S. Renewable Fuel Standard could incentivize pulpwood biofuel as an eligible compliance 
option if this pathway is approved. We also consider the growing demand for biomass in electricity 
production in the U.S. For the EU RED, the total expected heat and power demand is taken from 
National Renewable Energy Action Plans for all EU Member States. Our scenarios assume that 
40% of the target for renewable heat and power in EU is met with wood chip, and subtract 
estimated consumption of biomass in 2014 to project the demand increase from the present. The 
EU RED is binding through the year 2020, and we assume constant levels from 2020 to 2022 to 
be able to compare with the U.S. RFS outcomes. For the U.S. RFS, we assume total cellulosic 
biofuel production of 1 billion gallons in 2022, which is roughly consistent with the current growth 
of the industry from 2013-2016 according to historical production and EPA’s projections, and that 






of 105.7 gallons per tonne biomass, based on a futuristic yield from Bloomberg New Energy 
Finance [103]. 
Note that our current scenario analysis is based on possible implementation pathways of 
existing policies (e.g., RFS), not bioenergy in general. The possible pathway is using wood chip 
as a bioenergy feedstock. Our scenarios analysis can be cited as strategies to help meet broader 
energy and climate policies such as Paris Agreement goals, which doesn’t specifically address how 
bioenergy should be used to meet the target. 
After running our model under different scenarios, we looked at the resulting supply from 
each region and compared it to the base case. We were specifically interested in which regions 
increase their supply significantly in each scenario. 
4.3.2 Specific Scenarios 
In Figure 4.1 and Figure 4.2, we show the results for the following five specific scenarios: 
1. The U.S. increases its demand for wood chip by 2.37 million tonnes for biofuel, 
corresponding to 250 million gallons of pulpwood ethanol in 2022. 
2. EU increases its demand for wood chip by 34.78 million tonnes, corresponding to 40% 






3. U.S. increases its demand by 2.37 million tonnes for biofuel and EU increases its 
demand by 34.78 million tonnes, corresponding to 250 million gallons of pulpwood 
ethanol and 40% of the EU’s renewable energy mandate in 2020-2022. 
4. U.S. increases its demand by 2.37 million tonnes for biofuel plus 25 million tonnes for 
power, corresponding to 250 million gallons of pulpwood ethanol and expected growth 
in U.S. biomass power in 2022. 
5. U.S. increases its demand by 2.67 million tonnes for biofuel plus 25 million tonnes for 
power and EU increases its demand by 34.78 million tonnes, corresponding to 250 
million gallons of pulpwood ethanol, expected growth in U.S. biomass power and 40% 







Figure 4.1 Comparison of export of wood chip from different regions between the base case and 
the first three scenarios. Exports from the Middle East, North Africa, Central America and South 
Asia were omitted here because they are negligible. Base case: actual exports in the year 2011. 
Scenario 1: Increase in U.S. demand for cellulosic biofuel. Scenario 2: Increase in EU demand 







Figure 4.2 Comparison of export of wood chip from different regions between the base case and 
the fourth and fifth scenarios. Exports from the Middle East, North Africa, Central America and 
South Asia were omitted here because they are negligible. Base case: actual exports in 2011. 
Scenario 4: Increase in U.S. demand for cellulosic biofuel and biomass power. Scenario 5: 
Combined increase in U.S. demand for cellulosic biofuel and biomass power and EU demand for 







4.4.1  Base Case Results 
The base case represents the actual trade of wood chip between regions in the year 2011. Table 4.4 
displays the trade between major exporters and major importers and a summary of the major export 
and import data for that year. The largest flow of wood chip between regions is from Southeast 
Asia to East Asia. Southeast Asia, mainly Vietnam and Thailand had boosted their export since 
2010 to satisfy East Asia, especially China’s fast-growing demand for wood chip for paper and 
pulp production. Oceania is the second largest wood chip supplier for East Asia and has been a 
major exporter worldwide since 1997 because of the demand from Australia. The EU mainly 
imports wood chip from Latin America and the Former Soviet Union. The Middle East also has 
been a major importer, largely due to a recent increase in Turkey’s wood chip demand. Besides 
the year 2011, our analysis using the year 1997 to 2011 data shows that historically, Latin America, 
North America, South East Asia and Oceania have been major exporters of wood chip and the 
major importers are South East Asia and European Union. Hillring also identified those regions 







Table 4.4 Major trade of wood chip in the year 2011. Trade quantity was measured in thousand 
cubic meters. Row names represent major exporters and column names represent major importers. 
The column and row ‘Percentage’ represent each region’s percentage of global imports or exports. 





( 𝐾 𝑚3) 
Middle 
East 
( 𝐾 𝑚3) 
Canada 
 









Southeast Asia 15,103 0.277 0.075 0.001 0.001 15,103 31.1 
Latin America 5,820 3,479 424 0.001 314 10,058 20.7 
Oceania 9,736 0.693 0.001 0.001 1000 9,757 20.1 
USA 1,517 64 1,989 2,004 0.194 5,659 11.7 
Former Soviet 
Union 
207 2,691 1 0.001 0.246 2,899 6.0 
Sub-Saharan 
Africa 
2,258 189 0.001 0.001 0.001 2,501 5.2 
Total Imports 35,240 6,626 3,191 2,004 1,180   
Percentage (%) 72.6 13.6 6.6 4.1 2.4   
 
One obvious characteristic of these trade flows is that exporters tend to supply wood chip 
to geographically closer regions. Even though Southeast Asia is a major exporter and the EU is a 
major importer, there is almost no trade from Southeast Asia to the EU. The reason is very likely 
that the shipping cost from Southeast Asia is too high. Intuitively, these trade flows make sense 






 Another characteristic is that the U.S. and Latin America’s exports are more dispersed to 
different regions. Both regions export significant quantities to East Asia and the EU, and also to 
the Middle East, and Latin America exports large quantities of wood chip to other European 
countries. 
4.4.2 Scenario Results  
Figure 4.1 and Figure 4.2 shows the export of wood chip for scenario 1 to 5 compared with the 
base case for each region. Figure 4.3 and Figure 4.4 shows the major changes of trade flow of 
wood chip for scenario 1 and scenario 3. The quantitative scenario results for major changes of 







Figure 4.3 Global wood chip trade flow changes for scenario 1. Red arrows show an increase 
and green arrows show a decrease in the trade as results for scenario 1 when compared to the 
base case. The width of the arrow represents the relative magnitude of the trade flow changes. 
Please see Table 5 for the actual values. Here 11 regions were filled with different colors. The 







Figure 4.4 Global wood chip trade flow changes for scenario 3. Red arrows show an increase 
and green arrows show a decrease in the trade as results for scenario 3 when compared to the 
base case. The width of the arrow represents the relative magnitude of the trade flow changes. 
Please see Table 6 for the actual values. Here 11 regions were filled with different colors. The 









Table 4.5 Major changes in trade between major regions for the first scenario compared to the base 
case in the year 2011. Trade quantity was measured in thousand cubic meters. Row names 
represent exporters and column names represent importers. Positive numbers mean trade increased 





















Southeast Asia 2,096 0.019 0.031 0.006 0 0.008 
European 
Union 
-1 0 -4 655 -406 -26 
Latin America -132 -80 1,141 0.03 404 0 
Oceania 96 0 0 0.006 3 7 
USA -1,517 -64 -1,989 -1,077 -0.194 0 
Former Soviet 
Union 
37 324 1 0.006 0.2 0 
Sub-Saharan 
Africa 
-9 -0.743 0 0.006 0 0 










Table 4.6 Major changes in trade between major regions for the third scenario compared to the 
base case in the year 2011. Trade quantity was measured in thousand cubic meters. Row names 
represent exporters and column names represent importers. Positive numbers mean trade increased 





















Southeast Asia 10,037 8 0.475 0.015 0 0.108 
European 
Union 
-2 0 -25 -0.102 -865 -105 
Latin America -5,820 48,758 183 0.077 818 0 
Oceania 365 2 0 0.015 47 105 
USA -1,517 -64 -1,989 -1,102 -0.194 0 
Former Soviet 
Union 
-207 15,412 -1 0.014 -0.034 0 
Sub-Saharan 
Africa 
-2,258 3,469 0 0.015 0 0 
Canada -598 3 2,161 0.015 0 8 
 
From Figure 4.1, we can see that for the first three scenarios, the main regions that provide the 








Table 4.5 displays the trade flow changes when only the U.S. increases its demand for 
wood chip by 2.4 million tonnes for biofuel. Increasing demand will limit the U.S.’s export to 
other countries, as it will only consume its domestic supply. As a result, other major wood chip 
importers will have to increase their imports from regions other than the U.S. In this scenario, the 
Middle East will increase its import from Latin America instead of the U.S. to satisfy its demand. 
Southeast Asia will increase its export to East Asia in place of the U.S. The Former Soviet Union 
will increase its export to EU in place of the U.S. 
Table 4.6 shows that if the EU and the U.S. both increase their domestic demand, exports 
from Latin America and the Former Soviet Union to the EU will soar. At the same time, Southeast 
Asia’s exports to East Asia will also increase significantly because all the other major exporters 
except Oceania will shift their export from East Asia to the EU. 
Figure 4.2 shows that if the U.S. further increases its demand by 25 million tonnes for 
power, in addition to the 2.4 million tonnes domestic demand increase for biofuel, the U.S. won’t 
be able to satisfy its demand and will become a net importer of wood chip. In this scenario, 
Canada’s export to the U.S. will increase significantly. Figure 4.2 also shows greatly increased 
exports from Latin America and Southeast Asia, and to a lesser extent, from the Former Soviet 
Union, to satisfy the combined mandates in the U.S. and EU (Scenario 5). 
Increased export from Latin America and Southeast Asia may have a negative 






policies and enforcement. For instance, Chile has already been experiencing a clearing of natural 
forest and plantation expansion for the past few decades [104], partly caused by increasing demand 
for timber and fuel wood product. Our data analysis also shows Chile has constantly been a major 
exporter of wood chip from 2001 to 2010, its export of wood chip is about 9% of global export of 
wood chip annually. So increasing exports of wood chip from Latin America may cause further 
clearing of natural forest and plantation expansion in Chile, which would likely have negative 
impacts on the environment and biodiversity [105]. Another example is Sumatra, Indonesia, where 
increased value of agricultural commodities eroded enforcement efforts and led to increased 
deforestation in the late 1990s [106], illustrating that increasing demand for forest products can 
put pressure on forest protection efforts. Also, there is already evidence showing that UK’s demand 
for wood pellets has threatened the wetland forests in the southern U.S. [107]. A Freedom of 
information request by environmental organization Biofuelwatch showed that British utility 
company Drax power requires wood from slow-growing trees, not forest residues or energy crops 
as its source of wood pellets [108][109]. 
4.5 Discussion 
Our results show that if a significant fraction of the cellulosic biofuel mandate under the RFS is 
met by pulpwood biofuel, this pathway would likely have indirect effects on the global wood 






these demand shocks and does not account for potential demand reduction for wood chip, and so 
we may overestimate the market effects of the RFS and RED; however, our analysis is illustrative 
of the type of effects that are likely to occur.  
Our results indicate that, to ensure sustainable development of wood chip bioenergy, 
environmental, social and economic sustainability criteria should be implemented especially in 
these potential major sourcing regions for bioenergy. On the supply side, in 2011, Janssen and 
Rutz identified that no specific biofuel sustainability certification system had been implemented, 
but several sustainability initiatives have been established by stakeholders and governmental 
bodies from Latin America [110]. On the demand side, EU-wide sustainability schemes and 
criteria exist for biofuel but not for biomass [71][111]. If sustainability criteria and a certification 
system regarding wood chip are implemented in these sourcing regions and if we can estimate the 
sustainable wood chip bioenergy potential, we may be able to tell whether deforestation will occur 
given the predicted scenario results from our model. More specifically, if the sustainable wood 
chip bioenergy potential from these regions can’t satisfy the increased demand for those scenarios 
and the sustainability scheme is not implemented in these regions, then theoretically it could lead 
to deforestation. If the sustainable wood chip bioenergy potential can’t satisfy the increased 
demand and sustainability criteria are implemented in these regions, deforestation may still happen 
due to potential leakage. For example, let’s say sustainable wood can be used for both furniture 






and lack of explicit sustainability criteria for furniture, the sustainable plantation owner will sell 
wood for bioenergy while cutting down non-sustainably certified wood for furniture. Therefore, 
implementation of sustainability criteria for bioenergy can reduce, but not eliminate unsustainable 
deforestation. Therefore, to predict whether increased demand for wood chip from the EU and US 
will cause deforestation in these major sourcing regions, we need to consider the sustainability 
constraints regarding wood chip, the amount of sustainable wood chip bioenergy from the sourcing 
regions and the potential leakage effect. Lamers et al. studied the impact of sustainability criteria 
on potential import and supply costs of global solid biomass trade to North-West Europe [112]. 
Their approach incorporated sustainability criteria using feedstock exclusion. However, this 
approach is not applicable to our analysis since we are studying a single type of feedstock. 
Incorporating sustainability constraints into our model will also lead to more realistic results in the 
future when the sustainability criteria are implemented in these major sourcing regions. However, 
estimating sustainable wood chip bioenergy potential is beyond the scope of this study. 
Nonetheless, our model can use the results from other studies to estimate sustainable wood chip 
bioenergy potential as input and answer the question regarding deforestation. 
Our results are dependent on the value of supply elasticities, but our methodology provides 
an approach to make an inference from limited and noisy wood chip trade data. Better data and 
better estimates of supply elasticities will allow for deeper insights. For example, Kristöfel et al. 






pellet in Austria by constructing demand and supply models [96]. Their demand and supply models 
include factors that affect both the quantity and price of wood pellet demand and supply such as 
the number of total installed pellet boilers, heating degree days and production capacity. These 
methods can be used to estimate elasticities with relevant data for wood chips as well. 
Meanwhile, technological, economic and policy factors regarding wood chip bioenergy 
have been changing such as combustion technology, quality standards, shipping costs, oil prices 
and phytosanitary rules. In future studies, we can include these factors as constraints and 
parameters into our model. For example, if we know quantitatively how much combustion 
technology has improved the efficiency of using wood chip as bioenergy, we can adjust the demand 
for wood chip accordingly in our model. 
For future work, we propose a more nuanced representation of supply and demand. 
Detailed representation of the availability of wood chip through analysis of forest area, governance 
quality and production profiles will grant further validation to our results. If data of wood chip 
directly traded as bioenergy is available in the future, we can use that data and better estimate the 
effect of bioenergy policy on global trade of wood chip. Finally, a multi-period analysis will give 
better indications of trends over time. Our model is also amenable to be coupled with other policy 
models for the renewable fuel standard [113][114] [115], and can thus allow for a more robust 







Countries in Latin America, Southeast Asia, and the Former Soviet Union have great amounts of 
forest resource compared to other countries. Our study quantitatively shows that increased demand 
for wood chip from the U.S. and EU driven by a combination of renewable energy policies would 
increase harvests in these countries. Our methodology helps us answer the counterfactual questions 
for different bioenergy policy scenarios given limited data. This will assist policymakers to make 
sustainable bioenergy policies. If these countries have poor management and regulation of their 
forest resources, this may lead to the unsustainable development of wood chip bioenergy with 
negative impacts on carbon stocks, biodiversity, and rights of indigenous people. As a result, 
increased demand for wood chip from new renewable energy policies, including a pulpwood 
biofuel pathway under the RFS, may not deliver the full environmental benefits intended by those 
policies. To study whether these renewable energy policies will lead to the unsustainable 
development of wood chip bioenergy, further analysis by interviews with industry experts and 









5 Hyper-parameter Optimization for Support Vector 
Machines 
5.1 Introduction  
Machine learning models usually contain hyper-parameters that need to be optimized to prevent 
overfitting and minimize generalization error. Currently, the standard approach for assessing the 
generalization error of machine learning models is cross-validation [2][119]. The standard practice 
to optimize the hyper-parameters is using grid-search or random search combined with cross-
validation. Specifically, these methods search through a fixed (grid-search) or random (random 
search) set of values for the hyper-parameters and choose the one that yields the best model 






expensive especially given high-dimensional hyper-parameter space. Moreover, a locally optimal 
solution is not even guaranteed.  
Support vector machines (SVM) are popular and efficient methods for supervised learning, 
specifically, classification tasks [3]. They contain a regularization hyper-parameter 𝐶 to control 
for model complexity and overfitting. SVM can also have additional kernel hyper-parameters if 
we decide to use non-linear kernels, such as a commonly used kernel, Gaussian radial basis 
function kernels or RBF kernel. In practice, often grid-search or random search is used to choose 
the hyper-parameters. For more complex machine learning models, particularly, deep neural 
networks (deep learning models), the training process often involves tuning the hyper-parameter 
(most importantly, the learning rate, i.e., the step size in gradient descent method) manually while 
babysitting the training process. As the dimensionality of dataset becomes very large, it’s 
computationally expensive and inefficient to use those empirical ad hoc methods for hyper-
parameter tuning. On the other hand, choosing good hyper-parameters is very important to obtain 
trained machine learning models with good predictive performance on unseen test data. It is often 
the critical step for building complex nonlinear machine learning models such as deep neural 
networks, and SVM with nonlinear kernels.  
Researchers have started to create more efficient hyper-parameter tuning methods for 
machine learning algorithms in general. Hyper-parameter optimization has been naturally 






prediction error on unseen test data, also called the generalization error. On the inner or lower 
level, we are minimizing the error of model fitting on training data. Gradient-based methods for 
optimizing hyper-parameters have emerged as early as 1999 by Bengio [120]. Those gradient-
based methods mostly rely on the implicit differentiation trick. Precisely, those methods 
differentiate the upper-level loss function with respect to the hyper-parameters using an implicit 
equation (the optimality condition of inner optimization problem). For instance, Bengio (1999) 
[120] used a gradient-based method by computing the gradient of the loss function with respect to 
hyperparameters using the implicit function theorem to optimize multiple hyper-parameters for a 
general smooth training loss function, particularly the quadratic loss function. Chuong et al. (2007) 
[121] used gradient-based methods with the implicit function theorem to efficiently optimize 
multiple hyper-parameters for log-linear models. To avoid computing a demanding exact gradient 
in the implicit differentiation trick, Pedregosa (2016) [122] optimized the hyper-parameters with 
approximate gradients and provided numerical results on 𝑙2-regularized logistic regression and 
kernel Ridge regression models.  
Recently, new gradient-based methods have been emerging for hyper-parameter 
optimization for deep neural network models. These methods make the hyper-parameter tuning 
process faster and by overcoming expensive memory requirement while retaining good model 
performance [123][124][125][126]. Typical hyper-parameters for deep neural networks includes 






reverse-mode differentiation usually requires iterations of forward and backward pass of 
computations. It also requires storing the entire training trajectory for millions of intermediate 
parameters in memory, which is unmanageable. Maclaurin et al. (2015) [123] showed that, instead 
of storing the entire training trajectory, we could recompute the learning trajectory during 
backpropagation on the fly by storing few auxiliary bits. They demonstrated the idea for training 
procedure of stochastic gradient descent (SGD) with momentum. Fu et al. (2016) [124] 
demonstrated that a shortcut could be created to approximate the reverse-mode differentiation step 
by extracting the knowledge from the forward pass. Their algorithm is 45 times faster and requires 
100 times less memory compared to standard methods evaluated on two image datasets. 
SVM has a unique optimization problem structure, which can be explored and utilized to 
optimize its hyper-parameters. Existing methods mostly optimize the regularization hyper-
parameter C, not the kernel hyper-parameter λ due to the nonlinearity and computation complexity 
induced by λ. Hastie et al. (2004) [127] created a method that can trace the entire regularization 
path of SVM solutions for different values of the hyper-parameter 𝐶. Exploiting the fact that the 
dual variables of SVM are piecewise-linear in 𝐶, their method has the same computational cost as 
solving one SVM problem. Bennett et al. (2008) [128] and Kunapuli et al. (2008) [129] formulated 
hyper-parameter optimization as a bilevel optimization problem. They further reduced the problem 
to a single optimization problem by replacing the lower-level SVM with its optimality conditions, 






mathematical programming with equilibrium constraints (MPEC). The authors explored various 
general optimization methods for solving MPEC problems with limited success. The disadvantage 
of this approach is that the number of constraints grows linearly with the training data size, which 
makes the optimization problem intractable for large data. Moreover, it doesn’t exploit the 
particular structure of SVM to achieve a more efficient method. Couellan and Wang (2015) [131] 
took the same bilevel formulation as Bennett et al. (2008) [128] but used SGD with the implicit 
differentiation trick to optimize the hyper-parameter 𝐶 . Numerical results showed that their 
method is efficient for large datasets by exploiting the structure of SVM and performing cheap 
gradient estimate using SGD. However, SGD itself requires additional hyper-parameters, i.e., the 
learning rates. As Couellan and Wang’s (2015) [131] bilevel-SGD method requires performing 
SGD both on the upper-level and lower-level problems, it requires two additional hyper-
parameters to tune.  
To improve the bilevel-SGD method, we further exploited the structure of SVM. Precisely, 
we adopted a dual coordinate descent method (DCD) [12] for the lower-level problem and 
combined it with SGD on the upper-level problem. Our approach avoids introducing additional 
hyper-parameters for the lower-level problem. Numerical results on multiple benchmark datasets 
show our method converges fast and achieves good generalization performance. First, we present 






compare our approach with the bilevel-SGD method and show the empirical results on multiple 
benchmark datasets.  
5.2 Problem Setting 
5.2.1 SVM Optimization Problem 
For a binary classification problem, let’s define the training data as {𝒙𝑖 ∈ 𝑅
𝑝, 𝑖 = 1, … , 𝑁} and 
the binary labels as {𝑦𝑖 ∈ {−1,1}, 𝑖 = 1, … , 𝑁}, where 𝑝 is the number of features and 𝑁 is the 
number of samples. SVM is a maximum margin classifier that uses a hyperplane {𝒙: 𝑓(𝒙) =
 𝒙𝑻𝜷 + 𝛽0 = 0} to separate the feature space, where 𝜷 and 𝛽0 are the parameters to be learned. 
The decision function or classification rule is 𝐺(𝒙) = sign[𝑓(𝒙)] = sign[𝒙𝑻𝜷 + 𝛽0].  




 ‖𝜷‖ (5.1) 




 is the margin size between the data points and the separating hyperplane. The constraints 
ensure the training data was classified to be on the correct side of the two margins, i.e. 






{𝒙: (𝒙𝜷 + 𝛽0) = −1} that separates the training data into two classes and 
𝟐
‖𝜷‖
 is the margin size 
between the two separating hyperplanes. 
For the linearly non-separable, or soft margin case, hinge loss is introduced into Eq. (5.1). 
The optimization problem becomes minimizing the sum of the hinge loss and the inverse of margin 
size as follows: 
where max {0, 1 − 𝑦𝑖(𝒙𝑖𝜷 + 𝛽0)} is the hinge loss for classifying the training example. The loss is 
positive when the training example is incorrectly classified, i.e., when 𝑦𝑖(𝒙𝑖𝜷 + 𝛽0) < 1. Figure 
5.1 demonstrates how a soft margin SVM separates two-dimensional feature spaces into two 

















Figure 5.1 A linear support vector machine (SVM) classifier separates a two-dimensional 
dataset (simulated data) into two classes using a hyperplane learned after training.  
 
Note ‖𝜷‖ in (5.1) was changed to 
1
2
‖𝜷‖𝟐 in (5.2) for computational convenience and it 
doesn’t change the optimization problem. The decision function for prediction is still 𝐺(𝒙). 
Various SGD methods have been proposed to efficiently solve formulation (5.2) for large-scale 
datasets [132][133]. 
 The hinge loss function in (5.2) makes the objective function non-smooth. Classically, the 
problem (5.2) has been reformulated into a constrained quadratic programming problem by 

















𝑠𝑢𝑏𝑗𝑒𝑐𝑡 𝑡𝑜 𝑦𝑖 (𝒙𝑖𝜷 + 𝛽0) ≥ 1 − 𝜉𝑖     (𝑑𝑢𝑎𝑙 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒: 𝛼𝑖)  (5.3) 
 𝜉𝑖 ≥ 0,   𝑖 ∈ {1, … , 𝑁}     (𝑑𝑢𝑎𝑙 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒: 𝛾𝑖)   
5.2.2 SVM Dual Problem 
Eq. (5.3) is the primal problem for SVM. Its dual problem is a more straightforward quadratic 
programming problem that only involves one set of decision variables 𝛼𝑖. The dual problem is 
typically solved instead. Efficient decomposition and coordinate descend methods exits for solving 
it with large-scale datasets [134][12]. The constraints for the primal problems are all linear 
constraints, and its objective function is convex. Therefore, Slater’s condition is satisfied which 
implies strong duality holds [135]. As a result, we can solve the dual problem and obtain the same 
solution as if we solve the primal problem. Moreover, the KKT conditions are sufficient and 
necessary for optimality. We derive the dual problem from the Lagrangian function as follows: 
 
ℒ(𝜷, 𝛽0, 𝝃, 𝜶, 𝜸) =
1
2
‖𝜷‖2 + 𝐶 ∑ 𝜉𝑖
𝑁
𝑖=1











 ℒ(𝜷, 𝛽0, 𝝃, 𝜶, 𝜸) (5.5) 






First, to obtain 𝑚𝑖𝑛
𝜷,𝛽0,𝝃
 ℒ(𝜷, 𝛽0, 𝝃, 𝜶, 𝜸), we set the derivative of ℒ(𝜷, 𝛽0, 𝝃, 𝜶, 𝜸) with respect to 
𝜷, 𝛽0, 𝝃 to 0. 
 𝜕ℒ(𝜷, 𝛽0, 𝝃, 𝜶, 𝜸)
𝜕𝜷





Therefore, we have 𝜷 =  ∑ 𝛼𝑖𝑦𝑖𝒙𝒊
𝑇𝑁
𝑖=1 . 
 𝜕ℒ(𝜷, 𝛽0, 𝝃, 𝜶, 𝜸)
𝜕𝛽0




 𝜕ℒ(𝜷, 𝛽0, 𝝃, 𝜶, 𝜸)
𝜕𝜉𝑖
= 𝐶 − 𝛼𝑖 − 𝛾𝑖 = 0 
(5.8) 
Combing Eq. (5.6), Eq. (5.7), Eq. (5.8) into Eq. (5.4) and simplifying, we obtain: 
 































𝑠𝑢𝑏𝑗𝑒𝑐𝑡 𝑡𝑜 0 ≤ 𝛼𝑖 ≤ 𝐶 (5.10) 
 
∑ 𝛼𝑖𝑦𝑖 = 0
𝑁
𝑖=1







Platt (1998) created one of the first decomposition methods, sequential minimal 
optimization (SMO), to efficiently solve the dual problem [134]. Later Hsieh et al. (2008) proposed 
a dual coordinate descent method to solve the slightly reformulated problem in (5.12). Their 
approach is well suited for large-scale linear SVM problems [12]. It takes 𝑂(log (
1
𝜖
)) iterations for 
their DCD method to reach an 𝜖-accurate solution. 
By including the bias term 𝛽0 into the vector 𝜷 and append another constant column filled 




𝑇 , 1],     𝜷𝑇 ← [𝜷, 𝛽0] (5.11) 






















𝑠𝑢𝑏𝑗𝑒𝑐𝑡 𝑡𝑜 0 ≤ 𝛼𝑖 ≤ 𝐶,     𝑖 ∈ {1, … , 𝑁}  
where 𝑄𝑖𝑗 = 𝑦𝑖𝑦𝑗𝒙𝑖
𝑇𝒙𝑗, and 𝒆 is a unit vector.  
5.3 Bilevel Problem Formulation  








 𝐹(𝑥, ?̅?)  
𝑠𝑢𝑏𝑗𝑒𝑐𝑡 𝑡𝑜 𝐺(𝑥, ?̅?) ≤ 0 (5.13) 
 ?̅? = 𝑎𝑟𝑔𝑚𝑖𝑛
𝑥,?̅?
{𝑓(𝑥, 𝑦): 𝑔(𝑥, 𝑦) ≤ 0}  
where ?̅? is the optimal solution for the lower level optimization problem and 𝑥 and ?̅? both decision 
variables for the upper-level optimization problem. 
5.3.1 One-Fold Validation  
Usually, the hyperparameter is tuned by maximizing model performance on the hold-out dataset 
using k-fold cross-validation [119]. Let’s first consider a simple case using the same framework 
where we optimize the hyperparameter to maximize the model prediction performance on one 
separate validation set (𝑁 samples). Precisely, on the upper level, we are minimizing prediction 
loss on the validation set. On the lower level, we are solving the SVM problem itself. Let’s again 
ignore the bias term 𝛽0  using operation (5.11) and take the original SVM primal problem 
formulation, Eq. (5.2), as the lower-level problem. The bilevel problem formulation for hyper-











𝑠𝑢𝑏𝑗𝑒𝑐𝑡 𝑡𝑜 𝐶max ≥ 𝐶 ≥  0 (5.14) 
















𝑣 represents data in the validation set, and 𝒙𝑖 represents data in the training set.  
5.3.2 Related Work 
Couellan and Wang (2015) solved the above problem (5.14) using SGD [131]. The key challenge 
is to use SGD is to obtain the gradient estimate of 𝐹(𝐶, ?̅?) with respect to hyper-parameter 𝐶, 
∇𝐶𝐹(𝐶, ?̅?(𝐶)). To deal with this, they used the implicit differentiation trick and chain rule for 
deriving derivatives.  
Using chain rule, we obtain: 
 ∇𝐶𝐹 (𝐶, ?̅?(𝐶)) =  ∇𝐶𝐹(𝐶, ?̅?)
𝑇
+  ∇?̅?𝐹(𝐶, ?̅?)
𝑇
∇𝐶?̅?(𝐶) (5.15) 
When the lower level problem reaches the optimum solution, the sub-gradient equals zero, i.e., 
 
∇𝜷𝐺(𝐶, 𝜷) = 𝜷 − 𝑪 ∑ 𝑦𝑙𝒙𝑙  
𝐿𝑒
𝑙=1
= 0 (5.16) 
where 𝑙 is the index of the sample whose training loss is positive, i.e., {𝑙 = 1, … , 𝐿𝑒|𝑦𝑙𝜷
𝑻𝒙𝑙 < 1}, 
as the for the other correctly classified samples, the sub-gradient is just zero. 
They used SGD to solve the lower-level problem and randomly sampled one data instance to 
estimate the sub-gradient for each iteration. Eq. (5.16) was further approximated by  
 ∇𝜷𝐺𝑙(𝐶, 𝜷) = 𝜷 − 𝑪𝑦𝑙𝒙𝑙 = 0 (5.17) 







 ∇𝐶?̅?(𝐶) =  − ∇𝜷
2 𝐺𝑙(𝐶, 𝜷)
−1∇𝜷𝑪
2 𝐺𝑙(𝐶, 𝜷) (5.18) 
 
From Eq. (5.17) we can derive ∇𝜷
2 𝐺𝑙(𝐶, 𝜷) = 1 and ∇𝜷𝑪
2 𝐺𝑙(𝐶, 𝜷) = 𝑦𝑙𝒙𝑙 . Eq. (5.18) can be 
simplified as: 
 ∇𝐶?̅?(𝐶) =  𝑦𝑙𝒙𝑙 (5.19) 
They also used SGD to optimize the upper-level problem and estimated the sub-gradient 
∇?̅?𝐹(𝐶, ?̅?)  using one random data instance as an unbiased noisy gradient estimate. More 
specifically: 
 ∇?̅?𝐹(𝐶, ?̅?) =  −𝑦𝑝
𝑣𝒙𝑝
𝑣 , where 𝑝 ∈ {1, … , 𝑁𝑒|𝑦𝑝
𝑣𝜷𝑻𝒙𝒑
𝒗 < 1} (5.20) 
Inserting Eq. (5.20) and ∇𝐶𝐹(𝐶, ?̅?)
𝑇
= 0 into Eq. (5.15), they obtained: 
 ∇𝐶𝐹 (𝐶, ?̅?(𝐶)) = −𝑦𝑝
𝑣𝒙𝑝
𝑣 𝑦𝑙𝒙𝑙  (5.21) 
Then they optimized both the hyper-parameter 𝐶 on the upper level and model parameters 
on the lower level iteratively using simple SGD [131].  
The disadvantage of their approach is that they introduced two new hyper-parameters, the 
learning rates 𝛼𝑤
𝑡  and 𝛼𝐶
𝑡  for the upper-level SGD and lower-level SGD parameter updates. The 






5.3.3 Our Approach 
To further improve their method, we propose an approach to combine SGD and DCD methods to 
optimize the hyper-parameter 𝐶. We choose to optimize the SVM dual problem formulation on 
the lower level using a DCD method proposed by Hsieh et al. (2008), while keep using SGD to 
optimize the hyper-parameter 𝐶 on the upper level.  
The bilevel hyper-parameter optimization problem we are solving becomes: 
𝑀𝑖𝑛
𝐶,?̅?


























𝑠𝑢𝑏𝑗𝑒𝑐𝑡 𝑡𝑜 𝐶max ≥ 𝐶 ≥  0  
 ?̅? = 𝑎𝑟𝑔𝑚𝑖𝑛
𝜶
{𝑓(𝜶) = 𝒆𝑇𝜶 −
1
2
𝜶𝑇𝑄𝜶: 0 ≤ 𝛼𝑖 ≤ 𝐶} , ∀ 𝑖 ∈ {1, … , 𝐿} 
 
where 𝑄𝑖𝑗 = 𝑦𝑖𝑦𝑗𝒙𝑖
𝑇𝒙𝑗 for the training set and 𝒆 is a unit vector, 𝑀∗,𝑗 = 𝑦𝑗𝒙𝒋 (in training set).  
Using chain rule, we have: 
 ∇𝐶𝐹(𝐶, 𝜶(𝐶)) = ∇𝐶𝐹(𝐶, 𝜶)








Following the framework by Couellan and Wang (2015), stochastic gradient descent can 
be used to obtain a noisy unbiased estimate of the gradient by randomly choosing one data sample 
𝑞 in 𝐹(𝐶, 𝜶). 
 ∇𝐶𝐹𝑞(𝐶, 𝜶(𝐶)) = ∇𝐶𝐹𝑞(𝐶, 𝜶)
𝑇 +  ∇𝜶𝐹𝑞 (𝐶, 𝜶(𝐶))
𝑇
𝐽𝜶(𝐶) (5.24) 
 From Eq. (5.22), we have ∇𝐶𝐹𝑞(𝐶, 𝜶)







 Therefore, Eq. (5.24) becomes: 





The key is how to obtain 𝐽𝜶(𝐶). As we use the dual coordinate descent method by Hsieh et 
al. (2008) to solve the lower level problem [12], the optimality condition for the lower problem is 
that the projected gradient is zero, i.e., ∇𝑃𝑓(?̅?) = 0, where 𝑓(𝜶) = 𝒆𝑇𝜶 −
1
2
𝜶𝑇𝑄𝜶. According to 
Hsieh et al. (2008) [12], we have: 
∇𝑖
𝑃𝑓(𝜶) = {
∇𝑖𝑓(𝜶)                          𝑖𝑓 0 < 𝛼𝑖 < 𝐶
min(0, 𝛻𝑖𝑓(𝜶))           𝑖𝑓 𝛼𝑖 = 0         





The only 𝛼𝑖 that are a function of 𝐶 are the ones that are equal to 𝐶, i.e., the constraint 𝛼𝑖 ≤









1, 𝑖𝑓 𝛼𝑖 = 𝐶





The advantage of our approach is that we didn’t introduce any additional hyper-parameters 
to the lower level optimization problem by using the DCD method [12]. As the DCD method is 
very efficient for large-scale SVM problems, we believe the new approach to be computational 
fast, while achieving the optimal solution for hyper-parameter 𝐶.  
The specific algorithm for our approach is shown in Algorithm 1 below. As we combined 








5.3.4 𝑲-fold Cross-validation 
In practice, 𝑘-fold cross-validation is the standard approach to tune hyper-parameters [119]. We 







Let’s assume we randomly split the dataset into k folds. Denote the data in the 𝑘𝑡ℎ 
validation fold as (𝒙𝑖
𝑣𝑘 , 𝑦𝑖
𝑣𝑘), 𝑖 ∈ {1,2, … 𝑁}, where 𝑁 is the number of samples in the validation 
fold. The rest of the dataset, i.e., 𝑘 − 1 folds are the training data. Let’s denote the training data as 
(𝒙𝑖
𝑡𝑘 , 𝑦𝑖
𝑡𝑘), 𝑖 ∈ {1,2, … 𝐿} , where 𝐿  is the number of samples in the training data. Figure 5.2 
illustrates the data partition for 3-fold cross-validation.  
The objective function on the upper level becomes minimizing the average loss over the 𝑘 
validation folds. On the lower level, we are minimizing the loss for each of the 𝑘 corresponding 




 𝐹(𝐶, ?̅?𝑘) =
1
𝐾























𝑠𝑢𝑏𝑗𝑒𝑐𝑡 𝑡𝑜 𝐶max ≥ 𝐶 ≥  0  







𝑇𝑄𝑘𝜶𝑘: 0 ≤ 𝛼𝑘𝑖 ≤ 𝐶} 








𝑡𝑘 , 𝑀𝑘∗,𝑗 = 𝑦𝑗
𝑡𝑘𝒙𝑗
𝑡𝑘 and 𝒆 is a unit vector.  
Given the value of 𝐶, all the lower-level optimization problems are independent. Therefore, 






SGD+DCD method needed to perform 𝐾-sfold cross-validation is at step 15 in Algorithm 1. Here 







Figure 5.2 Data partition for 3-fold cross-validation. Each row represents a split of the original 
data into training and validation fold. Training fold is in green. The corresponding validation 
fold is in blue. 
Next, we are going to illustrate the effectiveness of our approach with numerical results on 






5.4 Numerical Experiment 
There are two main implementation issues that need to be clarified. First, a stopping criterion needs 
to be chosen. In practice, several stopping criteria are used. For instance, stop the algorithm when 
the accuracy exceeds a predefined threshold. Or simply stop the algorithm when the maximal 
number of iterations is reached. To compare the two methods, we used the second stopping 
criterion.  
Another implementation issue is how to initialize all the variables. For our SGD+DCD 
method, we initialized 𝜶 as zero vector as suggested by [12] because the solution of 𝜶 typically 
has only a few nonzero elements, which are the support vectors. For the bilevel-SGD method, we 
initialized all the variables following Couellan and Wang’s (2015) study [131]. Specifically, we 
randomly initialized the 𝜷 from a [0,1] uniform distribution. The learning rate for the lower level 
SGD was chosen to be 
1
𝑡




where 𝑡  is the 𝑡𝑡ℎ  iteration and 𝑝 is the number of features. Our SGD+DCD method used 
1
𝑡√𝑝|∇𝐶𝐹𝑞(𝐶,𝜶(𝐶))|
 as the learning rate 𝜂𝐶  for the upper level SGD. For both methods, the value for 
hyper-parameter 𝐶 was initialized to be 10−4. In addition, we set 𝐶min = 10
−4, and 𝐶𝑚𝑎𝑥 = 10
6 
for both methods. 






1. Cancer: Wisconsin diagnostic breast cancer dataset. The two classes are the benign or 
malignant diagnosis. Number of samples: 699, number of features 9. Source: UCI 
Machine Learning repository [136]. 
2. Pima: Diabetes data. The two classes are positive or negative diabetes diagnosis. 
Number of samples: 768, number of features: 8. Source: UCI Machine Learning 
repository [137]. 
3. SVMguide1: astroparticle dataset. Number of samples: 3089, number of features: 4. 
Source: LIBSVM – a Library for Support Vector Machines [138]. 
4. Connect: connect-4 game dataset. The prediction target is win or loss. Number of 
samples: 67557, number of features: 42. Source: UCI Machine Learning repository 
[139]. 
5. Magic04: gamma telescope dataset. The prediction target is whether a signal is high 
energy gamma signal or background signal. Number of samples: 19020, number of 
features: 10. Source: UCI Machine Learning Repository [140]. 
6. Xerostomia: head and neck cancer radiotherapy side effect dataset. The prediction 
target is whether a patient develops acute xerostomia after radiotherapy. Number of 
samples: 551, number of features: 943. A detailed description of this dataset is in 






7. Xerostomia recovery: head and neck cancer radiotherapy side effect dataset. The 
prediction target is whether a patient developed xerostomia recovered at 18 months 
post radiotherapy. Number of samples: 146, number of features: 943. A detailed 
description of this dataset is in Chapter 3 of this thesis. Source: Oncospace JHU [141]. 
All dataset features were preprocessed and scaled to be in the range of [-1,1]. The class 
labels were coded as 𝑦 ∈ {−1,1}. These three datasets were used by Couellan and Wang’s (2015) 
study. We used them here to compare the two methods. For 5-fold cross-validation, we created the 
five folds using stratified sampling to ensure each fold has the same distribution of the prediction 
labels. 
Table 5.1 reports the numerical results of the two methods. Accuracy is the prediction 
accuracy on the validation folds (hold-out data) by doing 5-fold cross-validation. 𝐶 is the final 
value obtained for the hyper-parameter. Running time is the total CPU (Intel Core i7-7700HQ) 
time spent on training the SVM model. We obtained the results presented in Table 5.1 by running 
each of the methods for 150 iterations. 
Table 5.1 Numerical results of the bilevel-SGD method and the SGD+DCD method. 
Dataset 















Pima 65.58 0.38 0.33 76.53 0.21 0.91 
SVMguide1 72.81 1.06 1.21 84.88 0.29 2.43 
Connect 72.77 0.0001 89.36 83.68 0.06 148.39 
Magic04 66.97 0.26 22.80 78.55 0.54 47.39 
Xerostomia 68.97 0.10 2.56 69.51 0.01 2.57 
Xerostomia 
recovery 
81.58 0.12 0.39 78.75 0.01 0.45 
 
From Table 5.1, it’s easy to see with a slight increase of running time, the SGD+DCD 
method achieved higher accuracy on the validation folds for all datasets except the xerostomia 
recovery dataset. For the Cancer dataset, xerostomia and xerostomia recovery dataset, the accuracy 
result is about the same. For all the other datasets, the SGD+DCD methods accuracies are more 
than 10% higher than the standard bilevel-SGD method. For high dimensional datasets, xerostomia 
and xerostomia recovery, the SGD+DCD has about the same running time with the bilevel-SGD 
method. For the other non-high dimensional datasets, the bilevel-SGD is relatively faster. 
To further compare the convergence results, we plotted the accuracy and loss profile on 
seven datasets for both methods in Figure 5.3 to Figure 5.9. We can see that the SGD+DCD method 
converges to the optimal solution much faster than the bilevel-SGD method. Also, the SGD+DCD 








                                              (a) Accuracy                                                        (b) Loss on the validation set 
Figure 5.3 The numerical results of running Algorithm 1 (our SGD+DCD) method and the 
bilevel-SGD method on the Cancer dataset. (a) shows the prediction accuracy on the validation 









                                                (a) Accuracy                                                        (b) Loss on the validation set 
Figure 5.4 The numerical results of running Algorithm 1 (our SGD+DCD) method and the 
bilevel-SGD method on the Pima dataset. (a) shows the prediction accuracy on the validation 









                                                (a) Accuracy                                                         (b) Loss on the validation set 
Figure 5.5 The numerical results of running Algorithm 1 (our SGD+DCD) method and the 
bilevel-SGD method on the SVMguide1 dataset. (a) shows the prediction accuracy on the 








                                                (a) Accuracy                                                         (b) Loss on the validation set 
Figure 5.6 The numerical results of running Algorithm 1 (our SGD+DCD) method and the 
bilevel-SGD method on the Connect dataset. (a) shows the prediction accuracy on the validation 








                                                (a) Accuracy                                                        (b) Loss on the validation set 
Figure 5.7 The numerical results of running Algorithm 1 (our SGD+DCD) method and the 
bilevel-SGD method on the Magic04 dataset. (a) shows the prediction accuracy on the validation 








                                                (a) Accuracy                                                        (b) Loss on the validation set 
Figure 5.8 The numerical results of running Algorithm 1 (our SGD+DCD) method and the 
bilevel-SGD method on the Xerostomia dataset. (a) shows the prediction accuracy on the 








                                                (a) Accuracy                                                        (b) Loss on the validation set 
Figure 5.9 The numerical results of running Algorithm 1 (our SGD+DCD) method and the 
bilevel-SGD method on the Xerostomia Recovery dataset. (a) shows the prediction accuracy on 
the validation folds as the algorithm proceeds; (b) shows the loss on the validation folds as the 
algorithm proceeds. 
 
5.5 Discussion and Future Work 
Even though the SGD+DCD converges to an optimal solution very fast, it’s computationally more 






both the lower and upper-level problems. As we know, SGD is fast due to cheap gradient updates. 
For our SGD+DCD method, we optimized the lower-level problem using DCD. DCD method 
iterates through all the variables on the lower level for each outer iteration. For DCD, the number 
of variables on the lower-level equals the number of training examples. Therefore, when the 
number of training examples is much larger than the number of features, DCD requires longer 
running time [12]. All the datasets we used (except the Xerostomia and Xerostomia Recovery data) 
are all low dimensional datasets. The largest number of features among the seven datasets except 
the xerostomia data is 42 (the Connect data), which is much smaller than its number of samples 
(699). DCD is well suited for high dimensional dataset where the number of features is larger than 
the number of samples [12]. As a result, we believe the SGD+DCD method will be 
computationally more efficient to tune the hyper-parameter for high dimensional datasets, as 
shown by the results on the high-dimensional Xerostomia and Xerostomia Recovery datasets. 
 There are two main reasons that our SGD+DCD method achieves better accuracy 
performance than the bilevel-SGD method. Using SGD for optimizing both the hyper-parameter 
𝐶 on the upper level and SVM parameters on the lower level is fast due to cheap gradient estimates. 
However, there are assumptions and approximations behind the bilevel-SGD approach, which 
enables our SGD+DCD method to achieve better accuracy performance. The first reason is that, 
for each iteration of updating hyper-parameter 𝐶, we are assuming the lower-level SVM problem 






especially in the early iterations when the lower-level SVM problem is far from converging to the 
optimal solution. Regarding this assumption, our SGD+DCD method is more appropriate than 
Couellan and Wang (2015)'s bilevel-SGD method as the DCD method converges much faster than 
the SGD method for solving the lower-level SVM problem. 
 The second reason is that Couellan and Wang (2015)'s method approximated the optimality 
condition of the lower-level problem using only one randomly sampled data instance when using 
SGD to optimize C. Specifically, they estimated the stochastic gradient using Eq. (5.17), which is 
an approximation of the true optimality condition (Eq. (5.16)). They computed the stochastic 
gradient using the implicit differentiation trick on the optimality condition. This is different from 
a regular SGD problem, where the stochastic gradient is usually computed from a loss function. 
We utilized the implicit differentiation trick as well to obtain the gradient of lower-level SVM 
parameter 𝜶 with respect to 𝐶, i.e., 𝐽𝜶(𝐶). However, to obtain 𝐽𝜶(𝐶), we didn't approximate the 
optimality condition of the lower-level SVM problem. Instead, we computed the exact gradient of 
𝐽𝜶(𝐶) using Eq. (5.26) and Eq. (5.27). This is both an exact and computationally cheap gradient 
calculation as most of the elements in 𝐽𝜶(𝐶)𝑖 are zero when the lower-level SVM problem reaches 
its optimal solution. 
 In summary, we developed an efficient hyper-parameter optimization method to optimize 
the regularization parameter 𝐶  for supoort vector machine by combining stochastic gradient 






yields consistently higher out-of-sample accuracy performance than an existing bilevel-SGD 










6 Conclusion and Future Work 
Through the last four chapters, we illustrated how we solved complex healthcare and energy 
systems problems utilizing machine learning and optimization techniques. As information 
technology advances, accumulating healthcare and energy data has revealed many critical 
problems we are facing in these systems. Together with the recent rapid development in machine 
learning and optimization modeling methods, previously intractable problems now become 
solvable. For instance, hospital readmission data reveals that heart failure patients have one of the 
highest 30-day readmission rates. By better managing hospital readmissions, we can not only 
reduce our ever-increasing healthcare costs but also improve patients’ treatment outcome and 
quality of life. The daily risk prediction model can help the physicians target patients with high 






radiation oncology department, patients’ quality of life is often compromised due to radiation-
induced side effects. Oncospace is an analytic relational database that centers on an informatics 
infrastructure established at the Johns Hopkins hospital in 2008. This database has been 
systematically capturing patients’ data at all phases of their care. Using prospectively collected 
patients’ assessments and treatment data, we were able to discover new knowledge about radiation 
dose effect on xerostomia. This new knowledge can help physicians and researchers better 
understand the sensitivity of salivary function given radiation dose.  
For energy systems, we were able to perform scenario analysis on potential US and EU’s 
renewable energy policies about wood chip using equilibrium modeling. Effective and sustainable 
renewable energy policies are crucial to reducing carbon emissions in order to mitigate climate 
change. Renewable energy policies are often created within a local region, such as within a country 
or a state. However, the scale of its impact on environmental sustainability can be global due to 
international trade of bioenergy products. We identified potential detrimental global sustainability 
issues with the policy in which the US is considering to include wood chip as a renewable energy 
source. Precisely, according to our model and historical wood chip trade data, the policy is likely 
to cause deforestation in countries in Southeast Asia, Latin America, and the Former Soviet Union. 
Finally, through Chapter 5, we have seen how optimization techniques can be used to 
improve the machine learning algorithms regarding hyper-parameter tuning. A more systematic 






needed to help us move away from ad hoc empirical approaches. Tuning hyper-parameters for 
deep learning models has been notably called art, not science. Gradient-based optimization 
techniques for hyper-parameter optimization have been emerging recently with the advances of 
deep learning. We demonstrated that applying the same framework but adapted to exploit the 
special structure of a classical machine learning algorithm, SVM, enables us to tune the hyper-
parameter for SVM efficiently.  
Despite the contributions and advances we have made to solve those problems in healthcare 
and energy systems, certain limitations exist. To overcome these limitations and ultimately solve 
those problems, I will discuss future directions of research for the projects described in Chapter 2 
to Chapter 5 next. 
6.1 Holistic Approach to Reducing Hospital Readmission 
Hospital readmission is a complex issue. Many factors can lead to hospital readmissions, not 
mention the uncertainties inherited in each of those factors. For instance, 30-day readmission for 
heart failure patients may be caused by being discharged with an unstable condition. Or patients 
tend to revisit hospitals more frequently because they live close to the hospitals, while patients 
who live further away from the medical facility avoid readmissions due to the geographical 
distances. Or patients who live with their family members could receive better care and tend to 






societal factors could affect the readmission rates. A holistic approach may be necessary to reduce 
hospital readmission rates. A holistic approach involves improving patients’ treatment during 
hospital stays and also patients-care post hospital discharges. It also requires a more complete data 
capturing process. Currently, the data available for studying hospital readmissions are mostly 
patients’ data collected during patients’ hospital stays. The data about patients’ care and health 
status post-discharge is often unknown. However, we believe that patients’ health status and care 
information post discharge may be more important for reducing readmissions. To collect patients’ 
data post-discharge is a challenging issue. First, we need the informatics infrastructures built out 
of the hospital. Second, closely monitoring patients’ health status post-discharge may encounter 
legal privacy issues.  
Finally, patients’ electronic health records can be shared across all the hospitals the patients 
visited. One challenge in our heart failure patient readmission prediction work is that patients 
sometimes were transferred to other hospitals. As a result, patients effectively dropped out from 
the study as our study hospital only has access to patients’ data within that hospital. Therefore, an 
informatics infrastructure that stores all the historical healthcare data for a patient across different 
hospitals will be extremely valuable. First, a complete historical healthcare dataset for each patient 
enables more accurate research results and findings, which leads to better understanding and 
treatment of diseases. Second, a complete healthcare record provides hospital more information 






 Regarding modeling patients’ readmission risk, a dynamic and multi-module prediction 
model that combines different types of patients’ information may be developed. A multi-module 
prediction model utilizes different modules of data and treats them separately. For instance, one 
module can be patients’ longitudinal laboratory test data. Another module is patients’ 
geographical, societal information. Patients’ treatment information can also be an important 
module. That information has different characteristics and can give different indications on 
patients’ health condition and readmission risk. Separate models can be built for predicting 
readmission risk using each module’s data. Finally, these models can be integrated into a multi-
module prediction model.  
In summary, we believe this holistic approach can help us successfully manage hospital 
readmissions, improve patients’ quality of life, and save healthcare cost.  
6.2 Optimal Treatment Planning Considering Toxicity in 
Radiation Oncology 
For this radiation oncology work, there are different goals. The ultimate objective is to optimize 
the radiation treatment plans for a head and neck cancer patients. A radiation treatment plan is 
considered optimal if it minimizes patients’ treatment side effects as well as maximizes its 
treatment effect of killing cancer cells. As we can see, this is a multi-objective optimization 






objectives. Higher radiation dose kills more cancer cells but leads to severe treatment side effects. 
Lower radiation dose can reduce treatment side effects, but also compromises the effect of killing 
cancer cells. We believe, a particular approach is to, first, predefine a treatment effect requirement 
on killing cancer cells. Given this requirement, we can optimize the radiation treatment plan to 
minimize the side effect for a patient. Essentially, we can reduce the multi-objective optimization 
problem into a single objective optimization problem with the requirement of killing cancer cells 
as constraints.  
To optimize treatment plan, another objective of this work is to understand how radiation 
therapy affects treatment side effects. Given the complex organ structures within head and neck, 
understanding this relationship is a difficult task, and it’s a popular ongoing research area. 
Understanding how radiation dose in different subvolumes affects side effects will enable us to 
optimize the treatment plans to minimize those side effects. For instance, if we know a region 
within the parotid gland is very sensitive to radiation but very important in preserving salivary 
function, we can try to avoid radiating this particular region during treatment planning.  
Currently, we used a regularized logistic regression model to study the spatial relationship 
between dose and xerostomia. The challenge is that our findings are limited by the dose variation 
within the patient cohort. Our current approach is not able to identify a causal relationship between 
spatial dose and xerostomia. Ideally, a clinical trial can be conducted to study the causal 






Another limitation of the current approach is that we treated each voxel dose features as an 
independent feature, without modeling the spatial dependencies between these individual dose 
features. We believe a model that captures the spatial dependencies between voxel dose features 
will improve our understanding of the spatial dose effect on side effects. It could also improve the 
prediction performance for predicting side effects. A convolutional neural network (CNN) is a 
supervised machine learning model that has been successfully used for image classification and 
medical image segmentation tasks [142]. By convoluting over the spatial input data using multiple 
sliding windows (filters), CNN can automatically learn spatial features in the input data. For 
instance, CNN can learn edges and various objects automatically from image data. Our voxel dose 
data is very similar to image dose. The only difference is that the voxel dose data is 3-dimensional, 
but the same technique of CNN applies to the 3-dimensional dataset. We can use a 3-dimensional 
sliding window to learn the spatial features. We have built a CNN model to use our 3-dimensional 
voxel dose data to predict xerostomia and currently optimize the model structure to improve its 
prediction performance. Once we have a CNN model with good predictive performance, we can 
use it for automatic feature discovery as opposed to performing feature engineering manually.  
6.2.1 Incorporating Toxicity Outcomes in Treatment Planning Optimization 
The goal for radiation treatment planning optimization is maximizing the dose delivered to tumor 
cells and minimizing the dose delivered to the surrounding normal organs and tissues. The original 








 𝐹(𝒙) = 𝛼1𝑓1(𝒙) + ⋯ + 𝛼𝒏𝑓𝑛(𝒙) (6.1) 
𝑠𝑢𝑏𝑗𝑒𝑐𝑡 𝑡𝑜  𝒙 ∈  ∁  
where 𝒙 is the planned radiation dose, and 𝛼 are the weights assigned to different objectives. 
 To explicitly incorporating toxicity outcome into the optimization problem, we can add the 
predicted risk of developing certain toxicity, for instance, xerostomia, to the objective function of 
the original optimization problem as another penalty term. The predicted risk is a function of the 
radiation dose 𝒙 estimated by our trained risk prediction model.  
In our case, we will use the trained ridge logistic regression model, instead of trained lasso 
logistic regression to predict the risk of toxicity. The reason is that trained lasso logistic regression 
model yields a sparse solution where only a small subset of the voxel dose features can be selected 
as the final features. If we use this sparse subset of voxel dose features as the decision variables in 
the optimization model, we will be only optimizing the radiation dose in that subset of voxels and 
wouldn’t be able to optimize the radiation dose in all the other regions, which is not applicable for 
our problem. On the other hand, ridge logistic regression doesn’t yield a sparse solution and assigns 
a non-zero weight for most of the voxel-dose features. Therefore, using the trained ridge logistic 
regression model, we would be able to optimize the radiation dose in all regions while minimizing 
its effect on predicted toxicity outcomes. 
Precisely, the new optimization problem explicitly incorporating predicted risk of toxicity 



















 is the predicted risk of toxicity using the trained ridge logistic regression 
model, 𝛾1  and 𝛾2  are the weights assigned to the original objective and the predicted risk of 
toxicity, and 𝒙 is the voxel-based radiation dose.  
6.3 Modeling Wood Chip Trade as a Biofuel 
The main challenge for this work is that there is not sufficient data available to distinguish wood 
chip traded for paper production versus for biofuel production. Most of the wood chip has been 
traded for producing papers historically. Renewable energy policies have increased the demand 
for wood chip as biofuel. To more realistically model the effect of renewable energy policies on 
wood chip trade, we should start recording trade data separately for wood chip traded for paper 
production and biofuel production. In other words, we should refine our trade data recording based 
on the final usage of the commodity. Given wood chip trade data for different usages, we can build 
a trade model which models wood chip for paper and biofuel production separately. Also, we can 
model the interaction or substitution effect between the two types of wood chip. We believe this 






6.4 Automatic Hyper-parameter Tuning for Machine 
Learning Models 
Emerging research on creating gradient-based methods for hyper-parameter tuning for machine 
learning models is expected to create machine learning algorithms that can tune hyper-parameters 
automatically. All of those methods rely on the implicit differentiation trick. The implicit 
differentiation trick enables us to obtain the gradient estimate for the hyper-parameters, which is 
the key for these methods. However, this approach has a large memory requirement, especially for 
deep learning models. We believe that, for future work, we can develop new ways to estimate the 
gradient for hyper-parameters that is memory efficient. Another option would be to keep using the 
implicit differentiation trick but exploring new techniques to overcome the high computational 
burden [123].  
As for hyper-parameter optimization for SVM, all current methods almost exclusively only 
optimized the regularization hyper-parameter 𝐶. No efficient methods exist for optimizing the 
nonlinear kernel hyper-parameters. This is due to the challenges induced by optimizing the 
nonlinear kernel hyper-parameters. SVM with nonlinear kernels usually require either storing the 
kernel matrix in memory or computing it on the fly whenever it’s needed. The kernel matrix has 
the same dimension as the number of training samples. Therefore, storing the kernel matrix for 






expensive. When we formulate the problem of tuning kernel hyper-parameters as an optimization 
problem, it often leads to a hard optimization problem with a highly nonlinear objective function 
and constraints. Further, performing the kernel estimation while optimizing the kernel hyper-
parameter is computationally expensive, especially for large datasets.  
Being able to use nonlinear kernels, is one of the main reasons that SVM is a powerful and 
popular machine learning method, and choosing the right value for the kernel hyper-parameters is 
crucial to obtain SVM models that work well. Therefore, being able to tune the kernel hyper-
parameters together with the regularization parameters automatically is challenging but extremely 
useful. To optimize the kernel hyper-parameters, we can exploit the special structure of the kernel 
functions and apply gradient-based methods in a bilevel optimization framework. To deal with the 
nonlinearity in the optimization problem, we can remove the nonlinearity by approximation for 
the nonlinear terms, for instance, using a piece-wise linear function. Approximated gradient 
estimates can then be estimated instead again using the implicit differentiation trick. We are 
currently investigating the exact optimization problem formulation for optimizing the kernel 









7 Appendix  
Data processing is often necessary and important before performing the analysis. The author has 
also spent great effort on data processing for the two projects in Chapter 2-3. Next, I will describe 
the specific data processing techniques I employed for each work.  
I also included other supplemental material in this chapter, such as how to use the prediction 
model for a particular patient in practice. 
7.1 Heart Failure Patient Readmission  
7.1.1 Data Cleaning and Feature Engineering 
Many of the data cannot be used directly from the heart failure patient database. Features need to 
be derived from the raw data. Therefore, in the beginning, a significant amount of time and effort 
was spent on cleaning the data and deriving features from the raw data. I performed three types of 






1. Obtaining numerical values: For example, I need to extract systolic blood pressure and 
diastolic blood pressure from blood pressure entry, convert weight and lab measures 
into the same unit. 
2. Feature categorization: Feature categorization for categorical features is another data 
cleaning process. Some categorical variables have too many values, but most of those 
values have small frequencies in the dataset. We manually aggregated those categorical 
variables into fewer categories using expert knowledge. 
3. Label generation: I derived a set readmission flags also a primary diagnosis label from 
the raw data. Those flags are our prediction target. They are: 
(a) Readmission within 30 days after discharge due to HF 
(b) Readmission within study window due to HF 
(c) All-cause readmission 
(d) All-cause readmission within 30 days after discharge 
(e) Readmission due to HF as the primary diagnosis 
(f) Readmission within 30 days due to HF as the primary diagnosis 






(h) Whether heart failure is an encounter’s primary diagnosis 
4. Feature engineering for complex features: For a complex feature like lab measures and 
procedures that have multiple repeated numerical values or a set of categorical values, 
I computed the frequency of measurement per day as its feature, e.g., the number of 
blood draws per day. For time series data including lab measures and vital signs, I 
created a feature template that computes detailed summary statistics described in 
Chapter 2 including gradients, mean, spread, maximal, and minimal value of the time 
series.  
5. Comorbidity features: I created a class that can take a list of ICD-9 codes and return an 
integer Charlson index based an ICD-9 code and Charlson scoring dictionary. Finally, 
I created Charlson index for three features: diagnoses, diagnosis history, problem list. 
6. Feature encoding: Categorical features do not have numerical order. The common way 
to deal with categorical data is to create dummy variables for each unique value of the 
categorical features. Then the dummy variable consists of binary values, which is the 
procedure I followed for feature encoding. 
7.1.2 Missing Data Imputation 
Another challenge is how to deal with missing values in our data set. We have missing values in 






First, I looked at the percentage of missing values for each feature. If the percentage of 
missing values for a certain feature exceeds 20%, I simply removed that feature instead of imputing 
the missing values. If the missing value is less than 20% for a certain feature, I imputed the missing 
value. 
Categorical features don’t have a significant amount of missing values and most categorical 
data are socio-demographical information. There are two obvious ways to treat missing values for 
categorical features. The first approach is that we simply treat missing values of that categorical 
feature as another dummy variable, which we may call it unknown. The second approach is similar 
to the imputing method we applied to continuous features. We can impute using the mode of the 
categorical feature or using its 𝑘 nearest neighbors. For this dissertation, I treated missing values 
as a new dummy variable. 
However, clinical data such as lab measurements and procedures have a significant amount 
of missing values most likely because that patient simply doesn’t have particular lab measurement 
or procedure. For features representing a count of certain clinical measures, a missing value can 
be treated easily by assigning a 0 to it. However, for features representing values of actual clinical 
measures such as the value of Troponin T or value of blood pressure, missing values need to be 
imputed. The way we impute these missing values is simply imputing by mean value across all the 
encounters. The disadvantage of this approach is that it decreases the variances for that feature. 






7.1.3 Data Transformation 
We often need to performance data transformation to improve optimization efficiency and machine 
learning performance. I applied two types data transformation to our data set: 
1. Feature scaling: The main preprocessing step for continuous features are feature scaling 
or feature standardization. Each features value may have very different scales and 
variance. To let the optimization procedure of the classifier, treat each feature equally, 
we need to standardize or scale our features. Gradient descent method will also 
converge faster with feature scaling. Otherwise, the features that have large values and 
variance will dominate the classification performance. The only classification methods 
that are feature scaling invariant are tree-based, such as Random Forest. Other 
classification methods like logistic regression and support vector machines need feature 
scaling. There are many different ways to scale or standardize features. The common 
ones are normalization and min-max scaling. Normalization normalizes the features to 
have mean 0 and unit variance. Minmax scaling scales the feature values to be within 
the range [0,1], a linear transformation. There is no obvious reason to choose one 
feature scaling method over the other. It depends on the application. In this dissertation, 







2. Feature transformation: We observed that most of the continuous features (lab 
measures, vital signs, etc.) are not normally distributed, but rather appear to follow a 
log-normal distribution. Some machine learning algorithms depend on the assumption 
that the features are normally distributed such as Gaussian Naive Bayes. So to improve 
classification performance, I experimented with log transformation as a data 






7.1.4 Trend of Dynamic Predictors 

































































































(q) Minimal ALT (Units/L) 
Figure 7.1 Value of 17 dynamic discriminative predictors from admission to discharge. 
7.1.5 Model Prediction for a Particular Patient 
Using the model to predict the readmission risk for a particular patient is standard. After we input 






can obtain the predicted readmission risk. However, in practice, we may still have follow-up tasks 
to perform after the prediction. For instance, the physician could want to know which features may 
be driving the high readmission risk for that patient if the predicted readmission risk is high. 
Knowing the important features for that patient is important to help the physician provide 
interventions to improve the patients’ health condition and lower the readmission risk. 
The specific steps for detecting the potential driving features for high readmission risk and 
providing interventions are as follows: 
1.  Go through all the dynamic lab tests and vital sign predictors in the model for that 
patient and find the ones that are out of the normal range. For instance, diastolic 
blood pressure higher than 90 mmHg indicates high blood pressure and we can 
mark this predictor for this patient. Let’s denote this subset of abnormal features as 
𝒙𝑎. 
2.  For each predictor 𝑥𝑖 in 𝒙𝑎, we set the value of 𝑥𝑖 to a normal value (for instance, 
70 mmHg for diastolic blood pressure). Then, we rerun the prediction model while 
fixing the values for all the other predictors. If the predicted readmission risk 
decreases, we mark this predictor as a potential predictor that can lead to 
interventions. We denote the set of these marked predictors as 𝒙𝑚. 
3.  For the predictors 𝒙𝑚 , we can rank them based on the amount of reduced 






For instance, among all the predictors in 𝒙𝑚, if setting the diastolic blood pressure 
to 70 mmHg leads to the lowest readmission risk, we rank diastolic blood pressure 
as the most important predictor for that patient.  
4.  The physicians can prioritize interventions based on the ranked list of important 
predictors 𝒙𝑚  for that patient. For instance, first, provide interventions to bring 
down the patient’s diastolic blood pressure level; second, provide interventions to 
increase the patient’s hemoglobin level. 
In the case where the physician is not able to provide interventions to bring back the value 
of important predictors to be exactly in the normal range, the odds ratio of each predictor can be 
used to rank those predictors in 𝒙𝑚. A larger odds ratio indicates a more important predictor, and 
thus can be guide for intervention.  
Although this provides a guideline for identifying important features for a particular 
patient, expert knowledge of physicians is needed to finally deliver interventions. 
 
7.2 Radiation Oncology  







For the radiation oncology work, two main data processing techniques were studied and applied: 
outlier detection and missing data imputation. Outlier detection was performed on patients’ weight 
outcome data. As xerostomia outcome was measured using a one to four scale, we didn’t observe 
any outliers in xerostomia outcome data. However, we have observed obvious outliers in the 
weight data. The values of weight are continuous and can have large variations. Therefore, it’s 
more prone to have outliers. A missing data imputation technique was also conducted for 
longitudinal weight data but not for xerostomia. The concern is that we won’t be able to reliably 
evaluate prediction model performance if the xerostomia outcome is imputed. Instead, we used 
last-observation-carry-forward to obtain the xerostomia outcomes for dropped-out patients. The 
popular method of multiple imputations by chained equations (MICE) was also explored for 
imputing missing features [144]. However, we didn’t apply this method due to its theoretical 
inconsistencies with our analysis.  
In the following section, I describe these two data processing techniques applied to the 
longitudinal weight outcome data for our patient cohort. 
7.2.1.1 Outlier Detection 
We used a metric called median absolute deviance (MAD) to detect the outliers. Assuming we 
have a time series of weight measurements for a patient, 𝑥𝑖, denote the median of 𝑥𝑖 as 𝑀(𝑥𝑖). 
Then we have MAD = 𝑚𝑒𝑑𝑖𝑎𝑛(|𝑥𝑖 − 𝑀(𝑥𝑖)|). Let’s define a threshold parameter 𝛾 to detect the 






large than 𝛾, i.e., 
|𝑥𝑖−𝑀(𝑥𝑖)|
𝑀𝐴𝐷
≥ 𝛾, we detected it as an outlier. Figure 7.2 shows the results of outlier 
detection using this method. The left figure is the raw data that contains outliers (shown as round 
dots), and the right figure shows the weight time series data after removing the outliers. 
 
Figure 7.2 Outlier detection for longitudinal weight outcomes. 
 
7.2.1.2 Missing Data Imputation 
For imputing missing longitudinal weight data, we applied two strategies. If the data is missing in 
the middle of two available measurements, we used linear interpolation to impute the missing data. 
If the data is missing due to dropouts, we imputed it using a dependent censoring model by Andrea 
and Robins (1995) [145]. Figure 7.3 and Figure 7.4 presents the results of applying this imputation 






the complete case. This illustrates why using a complete case will lead to a small bias in the sample, 
and this method can be used to correct this bias. 
 
Figure 7.3 Histograms comparing the weight distribution between complete cases and cases 








Figure 7.4 Cumulative density distributions comparing the weight distribution between 
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